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Foreword
It gives me great pleasure to present the 2016 Perinatal Mortality Re-
port from the National Perinatal Epidemiology Centre (NPEC). The 
most heartening aspect about this report is the amazing commit-
ment of the busy Irish maternity units to go beyond clinical care and 
contribute to this national audit in order to help improve perinatal 
outcomes for mothers, babies and their families.
It is wonderful to see the clear reduction in perinatal mortality de-
scribed in this report. While this finding is just one for one year, we 
would hope that this trend continues in the future. However, it is 
important that we do not focus on rates and numbers alone. We 
should remember that each perinatal death has a profound effect on 
a mother, a father and the extended family. 
A welcome and positive development to highlight is the implemen-
tation of recommendations from earlier perinatal reports, including: 
(1) All maternity units in the Republic of Ireland now contribute data 
to the NPEC audit on perinatal mortality; (2) With the support of the 
Faculty of Pathology, the NPEC has adapted the standardised ter-
minology for presenting placental pathology as per the international 
consensus1; (3) Recently, the adoption by the National Women and 
Infant’s Health Programme (NWIHP) of our recommendations for es-
tablishment of a confidential enquiry into unexpected intrapartum 
related deaths and the development of a national pathology service.
This report adds to a body of evidence to allow us to make inter-
national comparisons and learn more about perinatal mortality in 
Ireland. I commend that all healthcare professionals involved in the 
maternity service be aware of the findings in this report. 
Richard A Greene, Director, NPEC
National Perinatal Epidemiology Centre
5th Floor, Cork University Maternity Hospital
Wilton, Cork, Ireland
Email: npec@ucc.ie
Tel: +353 (21) 420 5017 
1 Khong TY, Mooney EE et al: Sampling and definition of placental lesions. Arch Pathol Lab Med.
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Introduction
This is the sixth report of the national clinical audit on perinatal mortal-
ity in the Republic of Ireland (ROI) using the NPEC data collection tool 
and classification system. It provides information on perinatal deaths 
arising from births occurring in the ROI during 2016. The report is divid-
ed into seven sections (Figure I) with additional information provided in 
the Appendices.
Since 2009 the NPEC, in collaboration with the multidisciplinary Perina-
tal Mortality Group (see Appendix B), has conducted a national clinical 
audit of perinatal mortality annually. The fundamental aim of this clinical 
audit, and a core function of NPEC, is to improve the care of mothers and 
babies in Ireland through the provision of key epidemiological evidence 
and monitoring of adverse perinatal outcomes. It is acknowledged that 
ongoing monitoring of quality and safety data is essential to continually 
drive improvements in the maternity services. The information provided 
in this report contributes to a body of evidence that will guide future 
clinical practice, counselling of bereaved parents, public health inter-
ventions and inform policy makers within the health services. 
Figure I: Sections of this 2016 Perinatal Mortality Report 
 Section 1 contains the main findings including
•  National and international comparison of perinatal mortality rates (PMR) and 
the impact of in utero transfer on individual unit’s PMR
• Distribution of Perinatal Deaths by the Robson Ten Group Classification System
• Maternal and infant characteristics impacting on adverse perinatal outcome
• Management of delivery in women experiencing perinatal loss
• Investigations to determine the cause of perinatal death
 Section 2 contains the invited expert commentary 
• “Reducing the Burden of Intrapartum Fetal Deaths” by Dr Karen McNamara
 Section 3, 4, 5 and 6: provides findings specific to (respectively) 
• Stillbirths
• Early neonatal deaths
• Perinatal deaths associated with intrapartum events
• Late neonatal deaths
  Section 7 presents data on Early neonatal deaths with a birthweight <500g 
and a gestational age at delivery of <24 weeks 
• These deaths are not included in the PMR
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This is the sixth report of the national 
clinical audit on perinatal mortality in 
Ireland using the NPEC data collection 
tool and classification system on cause of 
death. Anonymised data were reported 
by all 19 Irish maternity units on a total 
of 407 deaths arising from 64,133 births 
that occurred in 2016, of at least 500g 
birthweight or at least 24 weeks gestation. 
There was a statistically significant 
decrease in the perinatal mortality rate 
with the greatest decrease noted in early 
neonatal deaths. While this is a welcome 
finding, it must be acknowledged that this 
finding is just for one year. It is hoped that 
this downward trend in the rate of perinatal 
mortality continues in future years.
Stillbirths, early neonatal and late neonatal 
deaths accounted for 250 (61.4%), 124 
(30.5%) and 33 (8.1%) of the 407 deaths, 
respectively. The perinatal mortality rate 
was 5.8 deaths per 1,000 births; corrected 
for congenital malformation, the rate was 
3.6 per 1,000 births; the stillbirth rate was 
3.9 per 1,000 births; and, the early neonatal 
death rate was 1.9 per 1,000 live births. 
The corrected PMR of all but one of the 
19 maternity units were within the 95% 
confidence limits, indicating that they 
were consistent with the national rate. 
The exception had a high proportion of 
perinatal deaths following in utero transfer. 
If perinatal deaths following in utero 
transfer were excluded from the corrected 
PMR for this unit, it would be reduced 
by 13.3% and would be within the 95% 
confidence limits of the national rate.
Among mothers experiencing perinatal 
death, the proportion of women attending 
for their first antenatal visit at 20 weeks 
gestation or later, has continuously 
decreased in recent years from 11.3% in 
2013, to 4.8% 2016. The care of pregnant 
mothers was transferred in utero to another 
maternity unit in 9.6% of the perinatal 
deaths, most commonly to a tertiary 
referral maternity unit. 
An autopsy was undertaken following 
47.8% of perinatal deaths in 2016, slightly 
lower than the rate of 50.4% in 2015. 
Similar to previous years, a post-mortem 
examination was performed more often in 
stillbirths (54.2%) than in neonatal deaths 
(35.0%). 
There continues to be a high rate of 
placental histology examinations performed 
following perinatal death (96.8% in stillbirths 
and in 93.4% of early neonatal deaths).
Major congenital anomaly remains the 
primary cause of death in over thirty 
percent (31.2%) of stillbirths. Specific 
placental conditions were the second 
most common cause of stillbirth (28.0%). 
Similar to 2015, the cause of death was 
unexplained in approximately fifteen 
percent (15.2%) of stillbirths in 2016. A 
visible decrease in the percentage of cases 
due to infection was apparent in 2016 (from 
8.2% in 2015 to 3.6% in 2016). 
Major congenital anomaly was also the 
primary cause of neonatal death (54.8%). 
Respiratory disorder was the second 
most common cause of death, accounting 
for more than one in four (29%) of early 
neonatal deaths of which the majority 




Similar to early neonatal deaths, the 
primary cause of late neonatal death was 
major congenital anomaly (45.4%). As 
with previous years, the proportion of late 
neonatal deaths was found to decrease 
across the second, third and fourth weeks 
of life.
Low birthweight was associated with 
perinatal deaths, particularly with stillbirths. 
Almost half (47.2%) of all stillbirths were 
classified as severely small for gestational 
age (<3rd customised birthweight centile) 
compared to 25% of early neonatal deaths.
An association between maternal age 
and perinatal mortality was identified. 
Compared to mothers aged between 25-29 
years, women aged less than twenty-five 
years and greater than forty years had at 
least twice the rate of perinatal mortality. 
In terms of ethnicity and occupation, 
while the numbers involved were small, 
ethnic minorities and the unemployed 
were over-represented in the mothers who 
experienced perinatal deaths: this is similar 
to findings in 2015. 
As in previous years, increased body mass 
index (BMI) is associated with perinatal 
mortality. Over fifty percent (56.6%) of the 
mothers who experienced perinatal loss in 
2016 were either overweight or obese.
Perinatal deaths from multiple births 
accounted for 8.8% of all perinatal deaths. 
This is less than 2.5 times the proportion of 
multiples among all births in 2016 (3.8%).
While on-going clinical audit is essential 
to identify key factors influencing adverse 
perinatal outcomes, the opportunity to 
learn from the tragic event of a perinatal 
death would be greatly enhanced by the 
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Recommendations from previous reports 
being progressed by the National 
Women’s and Infants Health Programme.
•  The establishment of a confidential 
enquiry for stillbirth and neonatal death 
should be considered in order to enhance 
the lessons which may improve care. An 
initial step would be the establishment of 
a standardised review of a case series of 
unexpected perinatal deaths associated 
with intrapartum events.
•  Resourcing of perinatal pathology 
services on a regional and national basis, 
as recommended by the Faculty of 
Pathology, would provide equal access to 
review for all perinatal deaths nationally 
and would facilitate an agreed approach 
to classification of autopsy, placental 
histology and cytogenetics.
•  As recommended by the Institute of 
Obstetrics and Gynaecology, second 
trimester fetal anomaly ultrasound 
scanning should be universally available 
for all pregnant women in Ireland.
Based on the findings of this and previous 
reports, the NPEC Perinatal Mortality 
Advisory Group makes the following 
recommendations:
•  Improved antenatal detection of fetal 
growth restriction (FGR) with timely 
delivery is a preventative strategy to 
reduce perinatal mortality.2
–  Again, we recommend the generation of 
customised birth weight centile charts 
for every woman during pregnancy and 
concomitantly, staff should be trained in 
risk assessment, plotting of symphysial 
fundal height (SFH) and scan weight 
estimates in order to reduce stillbirths in 
Ireland.
–  Based on feedback to the NPEC, other 
methodologies could be considered. A 
multidisciplinary working group should 
be developed to address a national 
standardised approach to the detection 
of FGR. A national approach should also 
evaluate the use of a standard growth 
curve across all Irish maternity units. The 
Institute of Obstetrics and Gynaecology 
would be well placed to facilitate this 
working group.
•  Anonymised placental histology reports 
on perinatal death should be submitted to 
the NPEC as part of this audit: this would 
facilitate standardised interpretation and 
classification of placental conditions.
•  Further research exploring factors 
impacting on autopsy rates, particularly in 
the case of neonatal deaths, is warranted.
•  Funding should be provided by the 
Health Service Executive (HSE) to ensure 
that staffing levels allow protected time 
for clinical audit. Robust clinical audit of 
perinatal outcomes in all maternity units 
in Ireland is vital for patient care, but 
such audit requires the protected time of 
clinical staff. 
•  A public health education programme 
on perinatal deaths and modifiable risk 
factors should be developed. 
Recommendations 
2 Clinical Practice Guideline No 29 (2014). Fetal Growth Restriction Guideline - Recognition, Diagnosis and Management: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and 
Clinical Programmes, Health Service Executive.
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Figure II: Map of maternity units and hospital groups in the Republic of Ireland.
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In 2016, there were 19 maternity units 
in Ireland. Within each maternity, unit 
coordinators with the responsibility of 
submitting perinatal mortality data to the 
NPEC have been identified. Pseudonymised 
data on perinatal deaths from births 
that occurred between January 1 and 
December 31 2016 were submitted to the 
NPEC by all 19 units using a standardised 
notification dataset either electronically, 
via the secure online NPEC database, 
or alternatively by paper format (see 
Appendix E). The notification dataset is 
completed using data on fetal and maternal 
characteristics recorded in the clinical 
records. Implemented nationally in 2011, 
the NPEC notification dataset was based 
on the validated Centre for Maternal and 
Child Enquiries (CMACE) Perinatal Death 
Notification Form3 and has been endorsed 
by the Clinical Advisory Group at the 
Institute of Obstetrics and Gynaecology, the 
Faculty of Paediatrics and the HSE National 
Obstetric Programme Working Group. 
Figure III illustrates the NPEC data 
collection and management processes. 
There has been a steady improvement in 
the overall quality of data reported by all 
maternity units since the implementation 
of the NPEC perinatal mortality notification 
dataset in 2011. To ensure completeness and 
accuracy of information, all data is validated 
directly with the respective maternity 
units. The NPEC also undertakes extensive 
reconciliation of its annual perinatal 
mortality dataset with that of the National 
Perinatal Reporting System (NPRS). This 
consolidation with the NPRS is in response 
to recommendations by the Chief Medical 
Officer4 and ensures that both agencies 
datasets represent the most accurate 
record of perinatal mortality annually.
Methods
Data collection and management
3 Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
4 Holohan, T. (2014) HSE Midland Regional Hospital, Portlaoise Perinatal Deaths (2006-date). Dublin: Department of Health. 
Available at: http://www.lenus.ie/hse/bitstream/10147/313524/1/portlaoiseperinataldeaths.pdf 
Figure III: NPEC data collection and management processes 
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Rate calculations
To assess perinatal mortality, overall and 
unit-specific perinatal mortality rates 
(PMRs) per 1,000 births and corresponding 
95% confidence intervals based on the 
Normal approximation of the Poisson 
distribution were derived. Stillbirth, 
neonatal and corrected PMRs, which 
exclude deaths associated with or due 
to a congenital malformation, were also 
calculated. Denominator data on the 
number of live births and stillbirths were 
provided directly by the Healthcare Pricing 
Office (HPO). Perinatal deaths are included 
in a maternity unit’s rate if the baby was 
delivered in the maternity unit or if the unit 
was the intended place of delivery but the 
baby was born before arrival. 
Funnel plots
Variations in PMRs between maternity 
units could potentially be due to random 
chance or reflect differences in baseline 
characteristics of the childbearing 
population. For this reason, funnel plots 
were used to assess performance outcomes 
for individual units in comparison to the 
overall average.5 In brief, the plot is a 
scatter diagram of individual maternity 
unit mortality rates against the number of 
births within that unit. The national rate 
is indicated by the solid straight line. The 
95% confidence interval is indicated by 
the curved dashed line. The dashed lines 
represent the limits within which 95% of 
units are expected to lie (i.e. within two 
standard deviations). The 99.8% confidence 
interval for the national rate is plotted 
using solid lines. These solid lines represent 
the limits within which 99.8% of units are 
expected to lie (i.e. within three standard 
deviations). The width of the confidence 
interval is adjusted to allow for meaningful 
comparison between unit-specific rates 
and the national rate. The confidence 
interval is wider for smaller units reflecting 
the lack of precision in rates calculated 
based on small numbers. The confidence 
interval narrows for larger maternity 
units, giving the diagram a ‘funnel’ shape. 
Maternity unit rates outside the 95% and 
99.8% confidence interval are statistically 
significantly different from the national 
rate. In general, one in 20 units would be 
expected to lie outside the 95% confidence 
limits by chance alone whereas an 
observation outside the 99.8% confidence 
limits is especially rare, i.e. there is a 0.2% 
chance of this happening.
Birthweight centile
As with previous reports, we have 
produced charts to highlight the issue of 
failure of fetal growth in utero in relation 
to the stillbirths and early neonatal deaths 
that occurred in Ireland in 2016. To do so, 
we used the Gestation Related Optimal 
Weight (GROW) software6 and coefficients 
derived from the multiple regression 
analysis of data on 11,072 births in six 
maternity units in Dublin, Galway, Limerick 
and Belfast in 2008-2009.7
The regression analysis determined the 
Term (i.e. 40 weeks) Optimal Weight 
(TOW) in Ireland to be 3,490.7g. The 
normal range (i.e. the range from the 10th 
centile weight to the 90th centile weight) 
around the TOW was then calculated and 
the recommended proportionality growth 
function was applied to the TOW, the 10th 
centile term weight and the 90th centile 
term weight in order to determine the 
optimal weight and normal range at all 
gestations (21-44 weeks for the stillbirths 
and early neonatal deaths in Ireland in 
2016). These steps are described in detail in 
the GROW documentation.
5 Spiegelhalter D. (2002) Funnel plots for institutional comparison. Quality and Safety in Health Care; 11(4):390-91.
6  Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.6, 2013 Gestation Network, www.gestation.net
7  Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. 
The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
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Customised birthweight centiles were also 
derived using the GROW software. There 
was missing data for maternal height (n=41) 
and/or weight (n=51) with one or both 
unknown for 13.9% of the mothers (n=52). 
For these cases, we used the median height 
and weight of the mothers with complete 
data. The GROW software also provides 
estimated customised birthweight centiles 
in cases with missing data. Ultimately, 
customised birthweight centiles were 
calculated for all of the 374 mothers.
Classification of abnormal 
placental histology
Abnormal placental findings have been 
classified and presented under the 
following broad categories: maternal 
vascular malperfusion, fetal vascular 
malperfusion, cord pathology, cord 
pathology with distal disease, delayed 
villous maturation defect, chorioamnionitis, 
villitis and ‘other placental condition’ 
(Appendix F). This is in keeping with 
recommendations in a publication from 
an international consensus meeting 
of pathology.8 It is envisaged that this 
will optimise classification of placental 
conditions causing or contributing to 
perinatal loss.
Classification of death
The NPEC data collection form requests 
contributors to identify maternal, fetal 
and neonatal conditions, using specific 
categories, which caused or were 
associated with the death. The unit 
contributor is also requested to assign the 
principal cause of death with reference to 
the post mortem and placental pathology 
if performed. Guidance and definitions 
for completing specific categories are 
described in Appendix G. Briefly described, 
categories include both pathophysiological 
entities and clinical conditions present at 
time of death including placental pathology 
and Intra-Uterine Growth Retardation 
(IUGR). Classification of stillbirths was 
made using the NPEC maternal and 
fetal classification system. In the case 
of neonatal deaths, the NPEC neonatal 
classification system was used to attribute 
the main neonatal cause of death and the 
NPEC maternal and fetal classification 
system was used to identify the underlying 
obstetric condition/sentinel event 
associated with the death. 
Robson Ten Group Classification 
System
In 2016, 13 of the 19 units that participated 
in the perinatal mortality audit also 
provided data on all deliveries classified 
according to the Ten Group Classification 
System (Appendix H).9 This facilitated 
perinatal deaths to be classified according 
to the Ten Groups for these 13 units.
•  Recommendation: Funding should be 
provided by the Health Service Executive 
(HSE) to ensure that staffing levels allow 
protected time for clinical audit. Robust 
clinical audit of perinatal outcomes in 
all maternity units in Ireland is vital for 
patient care, but such audit requires the 
protected time of clinical staff. 
Definitions and terminology
While individual units define perinatal 
cases similarly, there is some variation. To 
allow for comparison across all units the 
NPEC used the following definitions for the 
current report:
Stillbirth: The NPEC seeks to apply 
a definition of stillbirth in accordance 
with the Irish Stillbirths Registration Act, 
which specifies stillbirth as a child born 
weighing 500 grammes or more or having 
a gestational age of 24 weeks or more who 
8 Khong TY, Mooney EE et al: Sampling and definition of placental lesions. Arch Pathol Lab Med.
9 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/S0965539501000122
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shows no sign of life.10 In previous reports, we 
considered delivery ≥24 gestational weeks 
to be coterminous with having a gestational 
age of 24 weeks or more. However, cases of 
fetus papyraceous, where one of twin fetuses 
died early in development, were not included 
as stillbirths. From 2016, cases of intrauterine 
death diagnosed before 24 gestational 
weeks with a birthweight <500g are not 
considered to have reached a gestational 
age of 24 weeks or more and thus are not 
included as stillbirths in this audit.
Early neonatal death: Death of a live born 
baby occurring within 7 completed days of 
birth. 
Late neonatal death: Death of a live born 
baby occurring after the 7th day and within 
28 completed days of birth. 
Live birth: Live birth refers to the complete 
expulsion or extraction from its mother of 
a product of conception, irrespective of the 
duration of the pregnancy, which, after such 
separation, breathes or shows any other 
evidence of life - e.g. beating of the heart, 
pulsation of the umbilical cord or definite 
movement of voluntary muscles - whether 
or not the umbilical cord has been cut or the 
placenta is attached. Each product of such a 
birth is considered live born.11 
Total births: For the purpose of calculating 
perinatal mortality rates, the denominator 
used was the number of births (live birth 
and stillbirths) from 24 weeks gestation or 
birthweight >500g.
Stillbirth rate: Number of stillbirths per 1,000 
births (live births and stillbirths from 24 weeks 
gestation or weighing >500g). The reporting 
guideline used by the Irish Healthcare Pricing 
Office perinatal statistics report on stillbirths 
uses the criterion of birthweight >500g.12 For 
consistency, we also report the stillbirth rate 
using the criterion of birthweight >500g.
Neonatal death rate: Number of early 
neonatal deaths per 1,000 live births (from 
24 weeks gestation or weighing >500g). 
The Irish Healthcare Pricing Office perinatal 
statistics report on early neonatal deaths 
with a birthweight >500g. For consistency, 
we also report the early neonatal death rate 
using the criterion of birthweight >500g.
Overall perinatal mortality rate (PMR): 
Number of stillbirths and early neonatal 
deaths per 1,000 births (live births and 
stillbirths from 24 weeks gestation or 
weighing >500g). Again for consistency with 
the Irish Healthcare Pricing Office reporting 
of perinatal statistics, we also report the 
neonatal death rate using the criterion of 
birthweight >500g. Late neonatal deaths are 
not included in the PMR.
Corrected PMR: Perinatal mortality rate 
excluding perinatal deaths associated with or 
due to a major congenital malformation.
Booking: Some data sought by the NPEC 
Perinatal Death Notification Form relate to 
the time of booking. Booking in this regard 
relates to the mother’s first antenatal visit at 
the maternity unit.
In utero transfer: From January 2016, the 
NPEC Perinatal Death Notification Form 
contains a specific question on whether the 
obstetric care of the mother was transferred 
to another maternity unit with the fetus in 
utero. The identity of the transferring unit 
and gestational age at time of in-utero 
transfer are also captured.
Parity: The number of completed 
pregnancies, whether live birth or stillbirth, 
of at least 24 weeks gestation or with a 
birthweight ≥500g. We refer to parity prior 
to the pregnancy that resulted in a perinatal 
loss in 2016.
Gravida: The number of times the mother 
has been pregnant, irrespective of duration. 
We refer to gravida prior to the pregnancy 
that resulted in a perinatal loss in 2016. 
10Stillbirth Registration Act, 1994. Available at: http://www.irishstatutebook.ie/eli/1994/act/1/enacted/en/print
11World Health Organisation. Available at: http://www.who.int/healthinfo/statistics/indmaternalmortality/en/
12Healthcare Pricing Office. Perinatal Statistics Report 2016. Dublin: Health Service Executive [in press]
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1. Main findings
Perinatal mortality rate
This section of the report provides details of 
the perinatal mortality rate (PMR), maternal 
and infant characteristics and autopsy uptake. 
In line with previous reports, the findings 
provided in this section relate to stillbirths and 
early neonatal deaths only. Separate sections 
are then provided for stillbirths, early neonatal 
deaths and late neonatal deaths describing 
clinical management and the main cause of 
death based on the NPEC Classification System.
The 19 Irish maternity units reported 
64,133 births with a birthweight >500g or 
gestational age >24 weeks. Of these, 407 were 
subsequently classified as perinatal deaths. 
Stillbirths, early neonatal and late neonatal 
deaths accounted for 250 (61.4%), 124 (30.5%) 
and 33 (8.1%) of the 407 deaths, respectively.
The reporting guideline used by the Irish 
Healthcare Pricing Office (HPO) in their 
publication of national perinatal statistics, uses 
the criterion of birthweight >500g. In 2016, 
the 19 Irish maternity units reported 64,097 
births weighing >500g of which 384 were 
subsequently classified as perinatal deaths. 
Stillbirths, early neonatal and late neonatal 
deaths accounted for 227 (59.1%), 124 (32.3%) 
and 33 (8.6%) of the 384 deaths, respectively.
As detailed in Table 1.1, the stillbirth rate 
associated with the criteria of birthweight 
>500g or gestational age >24 weeks was 3.9 
per 1,000 births and the early neonatal death 
rate using the same criteria was 1.9 per 1,000 
live births compared respectively to 3.5 and 
1.9 per 1,000 births based on birthweight 
>500g. The overall PMR was 5.8 deaths per 
1,000 births and when corrected for congenital 
malformation was reduced to 3.6 whereas the 
respective rates based on birthweight >500g 
were 5.5 and 3.3 per 1,000 births. 
Table 1.1: Frequency and rate of perinatal mortality outcomes, 2016
BWT ≥500g or gestational age ≥24 weeks BWT ≥500g
Number Rate (95% CI) Number Rate (95% CI)
Total births 64,133 64,097
Stillbirths 250 3.9 (3.4-4.4) 227 3.5 (3.1-4.0)
Early neonatal deaths 124 1.9 (1.6-2.3) 124 1.9 (1.6-2.3)
Perinatal deaths 374 5.8 (5.3-6.5) 351 5.5 (4.9-6.1)
Corrected perinatal deaths 229 3.6 (3.1-4.1) 212 3.3 (2.9-3.8)
Note: BWT=Birthweight; Rate per 1,000 births; 95% CI=95% confidence interval;  







































































































Stillbirths/1,000 births ≥28 weeks gestation
Figure 1.1: Irish stillbirth rate in 2016 compared to the stillbirth rate for 47 other high-income countries
Note: Rates based on stillbirths among births with ≥28 completed weeks of gestation. The Irish stillbirth rate, when corrected 
by excluding cases due to a congenital malformation, is adjusted to 2.1. *Indicates countries with fewer than 5000 births.
International comparison  
of the rate of stillbirth
An article published in 2016 in the Lancet’s 
Ending Preventable Stillbirths Series, compared 
the stillbirth rate across 48 high-income 
countries.13 The criterion for the stillbirth rate 
was gestational age ≥28 weeks. Based on this 
criterion, Figure 1.1 illustrates the 2016 Irish total 
stillbirth rate and the corrected Irish stillbirth 
rate, which excludes cases due to a congenital 
malformation in comparison to the reported 
stillbirth rate for the other 47 high-income 
countries. 
13  Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M, Khong TY, Silver RM, Smith GC, Boyle FM, Lawn JE, Blencowe H, Leisher SH, 
Gross MM, Horey D, Farrales L, Bloomfield F, McCowan L, Brown SJ, Joseph KS, Zeitlin J, Reinebrant HE, Ravaldi C, Vannacci A, Cassidy J, Cassidy P, 
Farquhar C, Wallace E, Siassakos D, Heazell AE, Storey C, Sadler L, Petersen S, Frøen JF, Goldenberg RL; Lancet Ending Preventable Stillbirths study 
group; Lancet Stillbirths In High- Income Countries Investigator Group. Stillbirths: recall to action in high-income countries. Lancet 2016; 387: 691–702.
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Comparison of perinatal mortality, 
2011-2016
Table 1.2 compares the perinatal mortality 
outcomes for 2016, based on the criteria of 
birthweight ≥500g or gestational age ≥24 
weeks, with those of the previous five years. 
As stated in the Definitions and terminology 
section of this report, cases of intrauterine 
death diagnosed before 24 gestational weeks 
and born after 24 gestational weeks with 
a birthweight <500g were not included as 
stillbirths in 2016. These cases were included 
as stillbirths in the previous five annual reports 
and there were 5-7 such cases each year, 
accounting for approximately 2% of the annual 
number of stillbirths reported. Revised figures, 
excluding these cases, are provided for 2011-
2015 in Table 1.2 and Figure 1.2 below. Thus, 
a meaningful assessment of changes over 
time can be made as the application of case 
definitions is the same across the period.
There was a notable decrease in perinatal 
mortality in 2016 compared to 2015, the largest 
year-to-year change observed during 2011-2016. 
Perinatal mortality rates were higher in the 
period before 2011-2016. Thus, 2016 is the year 
with the lowest perinatal mortality rates ever 
recorded in Ireland.
The largest relative year-to-year decrease was 
the 23% fall in the early neonatal death rate 
which was statistically significant (rate ratio, 
RR=0.77, 95% CI=0.61-0.97). The 15% decrease 
in the total PMR was also statistically significant 
(RR=0.85, 95% CI=0.74-0.97). The corrected 
PMR had a similar 16% decrease (RR=0.84, 95% 
CI=0.71-1.01) and the stillbirth rate was 11% lower 
in 2016 (RR=0.89, 95% CI=0.75-1.06). 
The time trend in each of the perinatal 
mortality rates is illustrated in Figure 1.2. The 
notable decreases in the rates in 2016 have 
reversed the effects of the smaller increases 
observed since 2011.
Table 1.2: Comparison of perinatal statistics, 2011-2016
2011 2012 2013 2014 2015 2016 RR (95% CI)
Total births N 74,265 71,755 69,146 67,663 65,904 64,133
Stillbirths
n 311 299 294 325 288 250
0.89 (0.75-1.06)
rate 4.2 4.2 4.3 4.8 4.4 3.9
Early neonatal deaths
n 137 141 162 141 166 124
0.77 (0.61-0.97)
rate 1.9 2.0 2.4 2.1 2.5 1.9
Perinatal deaths
n 448 440 456 466 454 374
0.85 (0.74-0.97)
rate 6.0 6.1 6.6 6.9 6.9 5.8
Corrected perinatal 
deaths
n 296 292 296 315 279 229
0.84 (0.71-1.01)
rate 4.0 4.1 4.3 4.7 4.2 3.6
Note: Rates are per 1,000 births; RR=Rate ratio comparing rate in 2016 versus rate in 2015; 95% CI=95% confidence interval; 
Corrected perinatal deaths exclude deaths due to a congenital malformation.
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Figure 1.2: Trend in perinatal mortality rates in Ireland, 2011-2016
Note: Rates per 1,000 births; PMR = perinatal mortality rate; Corrected PMR 
excludes deaths due to a congenital malformation. 
Variation by maternity unit
Based on birthweights ≥500g and/or gestation 
at delivery ≥24 weeks, the uncorrected PMR 
across the Irish maternity units ranged from 4.0 
to 7.8 per 1,000 births (Table 1.3); the corrected 
PMR ranged from 2.0 to 5.9 per 1,000 births. 
This level of variation across units is lower than 
that observed in recent years. There was also 
a positive correlation between the 2015 and 
2016 unit-specific corrected PMR, which has not 
been evident in recent years.
As reported earlier, there was a 17.1% decrease 
in the corrected PMR at the national level from 
4.3 per 1,000 births in 2015 to 3.6 per 1,000 
births in 2016. Year-to-year changes at the 
level of individual units are volatile due to the 
smaller numbers involved, however, there was a 
decrease in corrected PMR for 12 of the 19 units 
and the decrease exceeded 20% for eight units. 
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Table 1.3: Perinatal mortality rates across Irish maternity units in 2015 and 2016
Unit Uncorrected PMR (95% CI) Corrected PMR (95% CI) 
2016 2016 2015
1 7.8 (3.6-11.9) 4.4 (1.3-7.6) 2.7 (0.3-5.0)
2 7.6 (5.7-9.4) 5.2 (3.7-6.8) 5.1 (3.6-6.7)
3 7.5 (4.5-10.6) 4.7 (2.3-7.1) 6.1 (3.4-8.8)
4 7.4 (2.7-12.0) 5.9 (1.7-10.0) 5.9 (1.7-10.1)
5 7.2 (3.0-11.3) 3.6 (0.7-6.5) 3.5 (0.6-6.3)
6 6.7 (3.0-10.4) 4.6 (1.5-7.7) 3.4 (0.8-6.0)
7 6.3 (2.5-10.1) 4.0 (1.0-7.1) 5.1 (1.7-8.5)
8 6.3 (4.6-8.0) 3.8 (2.5-5.1) 4.3 (2.9-5.6)
9 6.0 (3.2-8.8) 3.7 (1.5-5.9) 4.4 (1.9-6.8)
10 5.6 (2.0-9.1) 3.3 (0.6-6.1) 5.8 (2.3-9.4)
11 5.5 (1.8-9.2) 3.1 (0.3-5.8) 5.0 (1.5-8.5)
12 4.8 (0.5-9.2) 2.9 (0-6.3) 2.8 (0-6.1)
13 4.7 (3.2-6.2) 2.6 (1.5-3.7) 3.6 (2.3-4.9)
14 4.7 (2.6-6.7) 2.0 (0.7-3.3) 3.6 (1.9-5.4)
15 4.6 (3.0-6.1) 2.5 (1.3-3.6) 4.8 (3.3-6.3)
16 4.3 (1.1-7.6) 3.1 (0.3-5.8) 2.9 (0.3-5.5)
17 4.3 (1.4-7.1) 3.3 (0.8-5.8) 5.0 (2.0-8.0)
18 4.3 (0.8-7.7) 2.8 (0-5.7) 2.8 (0-5.7)
19 4.0 (0.7-7.3) 2.7 (0-5.4) 1.9 (0-4.0)
All 5.8 (5.3-6.5) 3.6 (3.1-4.1) 4.3 (3.8-4.8)
Note: Rates per 1,000 births based on birthweights ≥500g or gestational age ≥24 weeks; PMR=perinatal mortality rate; 95% 
CI=95% confidence interval; Corrected PMR excludes deaths due to a congenital malformation; Two perinatal deaths were born 
outside of the maternity care and, therefore, were not included in the rates of any of the 19 units. 
The profile of mothers delivered may differ 
across Irish maternity units and this may explain 
variation in perinatal mortality rates. However, to 
establish this requires more detailed information 
on all mothers delivered at Irish maternity units 
than is currently available.
In utero transfer
In Ireland, women with high risk pregnancies 
may be transferred to the care of tertiary 
maternity units with facilities for specialist fetal 
medicine and high-level neonatal intensive care. 
Of the 374 perinatal deaths in 2016, there were 
36 cases (9.6%) where the care of the pregnant 
woman was transferred in utero.
The 36 in utero transfer cases in 2016 resulted 
in 12 stillbirths (33.3%) and 24 early neonatal 
deaths (66.7%). All but two of the 36 in utero 
transfer cases were transferred to one of the 
country’s four large maternity hospitals. For 
these hospitals in 2016, 17.3% (n=34) of their 197 
perinatal deaths arose from in utero transfer 
cases. This proportion varied across the four 
large maternity hospitals from 5.7% for one 
hospital, 12.5% for another, rising to 21.5% for 
the third hospital and 22.8% for the fourth. This 
shows the impact on perinatal mortality rates for 
these hospitals associated with in utero transfer.
The solid horizontal line in Figure 1.3 represents 
the national total or uncorrected PMR in 2016 
(5.8 deaths per 1,000 births) and the curved 
dashed lines represent the 95% confidence 
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interval around the national rate which should 
include the corrected PMR of individual units. 
Statistically, one in 20 observations can be 
expected to be outside the 95% confidence 
range. The PMR of one of the four large 
maternity hospitals, at 7.6 per 1,000 births, 
is just beyond the upper limit of the 95% 
confidence interval indicating that the rate is 
higher than the national rate in 2016.
In Figure 1.3, the blue diamonds represent 
each unit’s PMR. The red squares represent 
each unit’s PMR if there had been no in 
utero transfer cases, i.e. if all mothers who 
experienced perinatal loss after their care 
had been transferred in utero had still 
experienced perinatal loss whilst in the care 
of the maternity unit where she had intended 
to deliver at the time of her first antenatal 
visit. Without these in utero transfer cases, 
almost all of the country’s small maternity units 
would have had a higher PMR while the four 
large maternity hospitals would have had a 
lower PMR. The PMR of 7.6 of the outstanding 
maternity hospital would have been 21.5% 
lower at 5.9 per 1,000 births and thereby 
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Figure 1.3: Funnel plot of the uncorrected perinatal mortality rate (PMR) for Irish maternity units, 2016
Note: The blue diamond markers indicate the unit-specific PMR that was observed in 2016 and the red square markers the PMR 
that would have been observed if in utero transfer cases had remained at the unit where the booking appointment had taken place.
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Corrected PMR
The solid horizontal line in Figure 1.4 represents 
the national corrected PMR in 2016 (3.6 deaths 
per 1,000 births). The curved dashed blue 
lines represent the 95% confidence limits 
around the national rate and the curved blue 
lines represent the 99.8% confidence limits. 
Statistically, one in 20 observations, i.e. 5%, can 
be expected to be outside the 95% confidence 
limits whereas an observation outside the 
99.8% confidence limits is especially rare, i.e. 
approximately one in 500 observations. In 
2016, the corrected PMR of all but one unit was 
within the 95% confidence limits indicating 
that they were consistent with the national 
rate. The exception had a corrected PMR that 
was higher than the national rate though it 
was not outside the 99.8% confidence limits. 
This unit was one of the maternity hospitals 
noted earlier as having a high proportion of 
perinatal deaths following in utero transfer. 
If perinatal deaths following in utero transfer 
were excluded from the corrected PMR for this 
unit, it would be reduced by 13.3% and would 
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Figure 1.4: Funnel plot of the corrected perinatal mortality rate for Irish maternity units, 2016 
Note: Two units have similar rates of 3.06 and 3.08 (represented by overlapping diamonds). 
Figure 1.5 is a replicate of the funnel plot in 
Figure 1.4 as it also illustrates variation in the 
corrected PMR across Irish maternity units 
in 2016. For each unit, we have added error 
bars to illustrate the range in the unit’s annual 
corrected PMR since 2011 when the NPEC 
perinatal notification form came into use. 
Considering this six-year period, most of the 
units with over 2,000 births had their lowest 
corrected PMR in 2016.
The expected greater volatility in the rate 
associated with smaller units is evident. The 
plot also indicates how rarely a unit’s corrected 
PMR falls outside the limits of the 95% 
confidence interval or conversely it illustrates 
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Figure 1.5: Funnel plot of the corrected perinatal mortality rate and its variation for the years 2011-2016 in 
Irish maternity units 
Note: The error bars illustrate the variation in each unit’s annual corrected PMR since 2011. Two units have similar rates of 3.06 
and 3.08 (represented by overlapping diamonds).
In Figure 1.6, the solid horizontal line represents the national stillbirth rate of 3.9 per 1,000 births. 
The stillbirth rate of all maternity units was within the limits of the 95% confidence interval 
indicating that their rate was consistent with the national rate. 
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The solid horizontal line in Figure 1.7 represents the overall early neonatal mortality rate 
of 1.9 per 1,000 live births. One of the maternity units had a neonatal mortality rate on 
the upper limit of the 95% confidence interval and all others were within the confidence 
interval indicating their consistency with the national rate. 
































Total live births in unit (≥500g or ≥24 weeks)
Unit-specific rate Overall rate      95% confidence limits 99.8% limits
Distribution of Perinatal Deaths by 
Robson Ten Groups Classification 
System 
For the first year of this audit, we have 
presented data on the distribution of perinatal 
deaths by Robson Classification. The Robson 
Classification, also referred to as the Ten Group 
Classification System (TGCS), is a method 
providing a common starting point for further 
detailed analysis within which all perinatal 
outcomes can be measured and compared.14 
The system classifies all pregnant women 
into one of 10 categories that are mutually 
exclusive and, as a set, totally comprehensive. 
The categories are based on five basic obstetric 
characteristics that are routinely collected for 
all maternities: parity, gestational age, onset 
of labour, foetal presentation and number of 
foetuses.
In 2016, 13 Irish maternity units collated data 
on all births by each of the groups in the TGCS. 
The number of deliveries of infants in these 
units (n=51,367) constituted 80% of the total 
number of deliveries in the 19 Irish maternity 
units in 2016. These 13 units accounted for a 
similar proportion of the country’s 374 perinatal 
deaths in 2016 (n=309, 82.6%) and their overall 
PMR was 6.1 per 1,000 babies delivered. 
The TGCS of infants delivered in the 13 units 
during 2016 and their perinatal deaths are 
detailed in Table 1.4. On account of the small 
number of cases per category and the limited 
power of analysis in a small cohort, rates 
14 Robson M et al. The 10-Group Classification System (Robson classification), induction of labor, and cesarean delivery. International Journal 
of Gynecology and Obstetrics 131 (2015) S23–S27 
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per stillbirths and early neonatal deaths are 
not appropriate and as such not presented 
separately. Groups One through Five accounted 
for 90% of the deliveries in that year (n=45,188; 
89.8%) but represented only one in four of the 
perinatal deaths (n=82, 26.6%). The perinatal 
mortality rate across these five groups ranged 
from 0.6 per 1,000 for Group One to 3.6 per 
1,000 babies delivered in Group Four in contrast 
to the overall PMR of 6.1 per 1,000.
Groups Six through Ten accounted for 10% 
of deliveries where as three in four perinatal 
deaths were associated with one of these 
groups (n=226, 73.4%). Each of these groups 
had a greatly elevated PMR, ranging from 12.9 
per 1,000 for Group Eight women to 58.5 per 
1,000 for Group Ten. 
Prematurity is strongly associated with perinatal 
mortality. This is made especially clear by the 
TGCS. Group Ten contains all single cephalic 
pregnancies delivered preterm. This group 
contained 4% of the maternities, it had the 
highest PMR and contributed 2.4 per 1,000 
babies delivered to the overall PMR of 6.1 per 
1,000 babies delivered, i.e. 40%.
Table 1.4: Incidence of perinatal death by Robson Group in thirteen Irish maternity units, 2016








All* 51,367 100% 308 6.0 (5.4-6.8) 6.0
1 Nulliparous, singleton, cephalic, 
>37/40, spontaneous labour
8,843 17.6% 5 0.6 (0.2-1.3) 0.1
2 Nulliparous, singleton, cephalic, 
>37/40 induced or elective CS
8,198 16.3% 15 1.8 (1.0-3.0) 0.3
3 Multiparous (excluding previous 
CS), singleton, cephalic, >37/40, 
spontaneous labour
12,505 24.9% 19 1.5 (0.9-2.4) 0.4
4 Multiparous (excluding previous 
CS), singleton, cephalic, >37/40 
induced or elective CS
7,823 15.6% 28 3.6 (2.4-5.2) 0.6
5 Previous CS, singleton, cephalic, 
>37/40, induced or elective CS
7,819 15.5% 15 1.9 (1.1-3.2) 0.3
6 All nulliparous deliveries with a 
single breech pregnancy
948 1.9% 28 29.5 (19.6-42.7) 0.6
7 All multiparous breech (including 
previous CS)
886 1.8% 42 47.4 (34.2-64.1) 0.8
8 All multiple pregnancies 
(including previous CS)
2099 4.2% 27 12.9 (8.5-18.7) 0.5
9 All deliveries with a single 
pregnancy with a transverse or 
oblique lie, including women with 
previous uterine scars
162 0.3% 7 43.2 (17.4-89.0) 0.1
10 All singleton, cephalic, <37/40 
(including previous CS)
2,084 4.1% 122 58.5 (48.6-69.9) 2.4
Note: Rate is per 1,000 babies delivered; 95% CI=Exact Poisson 95% confidence intervals. CS=Caesarean section;  
*Robson Group could not be determined for one perinatal death.
26 PERINATAL MORTALITY IN IRELAND 
Maternal characteristics
The findings presented below relate to 
characteristics of mothers of stillbirths and 
early neonatal deaths born with a birthweight 
≥500g or having achieved a gestational age ≥ 
24 weeks.
Age
The age of mothers experiencing perinatal loss 
was known for 355 of the 374 perinatal deaths 
in 2016 (98.7%). The mothers who experienced 
perinatal loss in 2016 ranged in age from 
teenage years (the youngest 17 years of age) 
through to late-forties (47 years of age). Their 
age distribution broadly reflected that of the 
population of mothers who gave birth in Ireland 
(Table 1.5). Over half of the population (52.3%) 
who gave birth in 2016 were aged 25-34 years, 
whereas a slightly lower proportion of mothers 
who experienced perinatal loss were in this age 
group (48.6%). The age profile of mothers who 
experienced a stillbirth was similar to that of 
mothers who experienced early neonatal death. 
An association between maternal age and 
perinatal mortality was identified (Table 1.6). 
Compared to mothers aged between 25-29 
years, women aged less than 25 years and 
greater than 40 years had at least twice the 
rate of perinatal mortality.
Table 1.5: Age distribution of mothers experiencing perinatal loss in 2016















<20yrs 11 (2.4) 12 (3.3) 1.7% 9 (3.6) 3 (2.5)
20-24yrs 43 (9.2) 39 (10.6) 7.9% 24 (9.7) 15 (12.3)
25-29yrs 101 (21.7) 43 (11.7) 17.3% 31 (12.6) 12 (9.8)
30-34yrs 142 (30.5) 136 (36.9) 35.0% 84 (34) 52 (42.6)
35-39yrs 123 (26.5) 101 (27.4) 28.6% 74 (30) 27 (22.1)
>40yrs 45 (9.7) 38 (10.3) 6.7% 25 (10.1) 13 (10.7)
Note: Values are shown as n (%) unless otherwise stated. *Maternal age unknown for five cases in 2016 (3 stillbirths and 2 early 
neonatal deaths) and six cases in 2015. 
Table 1.6: Comparing the relative risk of perinatal mortality by age group among mothers in 2016
Age group Rate per 1,000  
(95% CI)
Relative Risk  
95% CI
P-Value
<20yrs 10.8 (5.6-18.8) 2.87 (1.51-5.44) 0.001
20-24yrs 7.5 (5.3-10.2) 1.99 (1.29-3.06) 0.002
25-29yrs 3.8 (2.7-5.1) 1.00 (reference) -
30-34yrs 5.9 (4.9-7.0) 1.57 (1.11-2.21) 0.010
35-39yrs 5.4 (4.4-6.5) 1.43 (1.00-2.04) 0.052
>40yrs 8.6 (6.1-11.8) 2.28 (1.47-3.52) <0.001
Note: Maternal age unknown for five cases in 2016.
16  Healthcare Pricing Office. Perinatal Statistics Report 2016. In Press. Dublin: Health Service Executive. [in press]
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Ethnicity
Assessment of risk of perinatal loss associated 
with ethnic group is impeded by the absence 
of national data on ethnicity for the pregnant 
population in Ireland. The majority of mothers 
who experienced perinatal loss were of white 
Irish ethnicity (72.4%) (Table 1.7). This is close 
to the proportion of white Irish women in the 
female population aged 15-49 years enumerated 
by the National Census 2016. While the numbers 
involved were small, Irish Traveller, Asian and 
Black ethnicities were overrepresented in the 
mothers who experienced perinatal deaths in 
2016 (10.7%) compared to 5% of the female  
15-49 year-old population. 
Occupation
Lower socio-economic status has been 
shown to be associated with poor pregnancy 
outcomes.17 In the NPEC national clinical 
audit, data on the mother’s and father’s 
occupation at booking was sought. Data was 
not recorded for 32 (8.6%) of the 374 women 
who experienced perinatal loss, this was higher 
than the proportion of unrecorded occupation 
in 2015 (7.6%). Table 1.8 provides a high-level 
overview of the data that were provided on 
mother’s occupation alongside data available 
for the most comparable occupation categories 
for mothers of all births in Ireland (from the 
Perinatal Statistics Report 2016)18 and for the 
15-44 year-old female population from the 
National Census 2016.
Employment status was specified for 91.4% 
of the mothers for whom data were recorded 
(Table 1.8). It can be seen that unemployment 
status was recorded for 8.5% of the mothers 
experiencing perinatal loss compared to 4.5% of 
all mothers and 8.2% of the female population 
aged 15-44 years. The proportion of mothers 
engaged in home duties who experienced 
perinatal loss (18.4%) was slightly lower than 
the percentage of all women engaged in home 
duties who gave birth (20.5%) in 2016. 
Table 1.7: Ethnicity of mothers experiencing perinatal loss in 2016
Ethnicity Perinatal deaths  
2016
15-49 year-old female  
population, 2016
White Irish 270 (72.4) 77.1%
Irish Traveller 8 (2.1) 0.7%
Other white background 54 (14.5) 13.3%
Asian/Asian Irish 18 (4.8) 1.6%
Black/Black Irish 14 (3.8) 2.7%
Other/Mixed 6 (1.6) 1.8%
Not recorded/Missing 4 (0.8) 2.7%
Note: Values are shown as n(%) unless otherwise stated. Population data from the National Census 2016. 
Table 1.8: Occupation at booking of mothers experiencing perinatal loss in 2016
Occupation Perinatal deaths  
n=342
All births 19  
(%)
15-44 year-old female 
population*
Employed 226 (66.1) 73.1 57.8%
Unemployed 29 (8.5) 4.5 8.2%
Home duties 63 (18.4) 20.5 10.4%
Student 14 (4.1) n/a 21.1%
Others not in labour force 10 (2.9) n/a 2.5%
Note: Data not known on employment for 32 perinatal deaths. *Population data from Census 2016.
17  Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
18 Healthcare Pricing Office. (2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive. 
19  Healthcare Pricing Office. Perinatal Statistics Report 2016. Dublin: Health Service Executive. 
28 PERINATAL MORTALITY IN IRELAND 
Gestation at booking
Gestation at the time of the mother’s first 
antenatal visit to the maternity hospital was 
not recorded for 37 cases of perinatal death 
in 2016 (9.9%). Of those with data, almost 
one in four (25.2%) booked into hospital 
before 12 weeks gestation, two-thirds (69.7%) 
attended for antenatal care between 12 and 19 
weeks gestation (Table 1.9). The proportion of 
women presenting for first antenatal visit at 
20 weeks gestation or later has continuously 
decreased in the past years from 11.3% in 2013, 
to 4.8% in 2016 (Figure 1.8).
Table 1.9: Weeks gestation at date of first hospital booking in 2016








Less than 12 Weeks 100 (24.1) 85 (25.2) 57 (24.8) 28 (26.2)
12-19 Weeks 282 (68) 235 (69.7) 161 (70) 74 (69.2)
20 Weeks or Later 30 (7.2) 16 (4.8) 11 (4.8) 5 (4.7)
Not Booked 3 (0.7) 1 (0.3) 1 (0.4) 0 (0)
Note: Values are shown as n (%) unless otherwise stated. Total perinatal deaths n=337, gestation at booking unknown for 32 
perinatal deaths and not recorded for 5 cases.
Figure 1.8: Proportion attending first booking appointment ≥20 weeks gestation among women who 
experienced perinatal loss in 2011-2016 
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Fertility treatment 
Currently in Ireland there is no national data 
on the number of births as a result of fertility 
treatment. The NPEC Notification Form contains 
a specific question on whether the pregnancy 
resulting in perinatal loss was the result of 
fertility treatment. In 2016, information was 
available for 350 of the 374 (93.6%) cases of 
perinatal death. In 26 of these cases (7.4%) the 
pregnancy was reported to be the result of 
fertility treatment (n=12 of 239 stillbirths, 5.02%; 
n=14 of 111 early neonatal deaths, 12.6%). Eleven 
of these 26 pregnancies (42.3%) were associated 
with multiple births ending in perinatal loss of 
one or more infants. 
The method of treatment was specified for 24 
of the 26 (92.3%) pregnancies resulting from 
fertility treatment. In order of frequency, the 
methods were: in vitro fertilisation (including 
egg donation and Intracytoplasmic Sperm 
Injection (ICSI) and other types) (n=16), clomid 
therapy (n=4) and other (n=4). 
Body mass index
Increased maternal body mass index (BMI) 
has been associated with an increased risk 
of congenital anomaly and stillbirth.20, 21 The 
recording of BMI in maternity records is a key 
recommendation of the Obesity and Pregnancy 
Clinical Practice Guideline. While this may be 
common practice in maternity units, no national 
data on the BMI of the pregnant population are 
available.22
BMI was available for 330 of the 374 of women 
who experienced perinatal loss in 2016 (Table 
1.10). The BMI of 41.5% of these mothers was 
in the healthy range (18.5-24.9kg/m2), which 
is similar to the previous years. In each of the 
six years, 2011-2016, over fifty percent of the 
mothers (56.6% in 2016) who experienced 
perinatal loss were either overweight or obese, 
albeit with fluctuation in the distribution of 
these two groups. The pattern of BMI in the 
mothers who experienced perinatal loss remains 
similar to that in the women from the general 
population who participated in the 2015 Health 
Ireland Survey.23




















Underweight (<18.5) 2 (0.6) 6 (1.7) 7 (1.7) 5 (1.2) 6 (1.8) 3%
Healthy (18.5-24.9) 161 (46.3) 164 (45.6) 183 (45.4) 182 (43.8) 137 (41.5) 44%
Overweight (25.0-29.9) 116 (33.3) 98 (27.2) 110 (27.3) 130 (31.3) 114 (34.5) 31%
Obese (≥ 30.0) 69 (19.8) 92 (25.6) 103 (25.6) 99 (23.8) 73 (22.1) 22%
Note: Values are shown as n (%) unless otherwise stated; *Percentage refers to the total 330 cases for which BMI was obtained. 
20 Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis. 
Am J Obstet Gynecol 2008;198:611-9
21  Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, et al. Maternal obesity and risk of stillbirth: a metaanalysis. 
Am J Obstet Gynecol 2007;197:223-8.
22  Clinical Practice Guideline No 2 (2011). Obesity and Pregnancy: Institute of Obstetricians and Gynaecologists, Royal 
College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.
23  Ipsos MRBI (2015).Healthy Ireland Survey 2015. Dublin: The Stationery Office.
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Smoking and substance abuse
Smoking status of the mothers at their time of 
booking was recorded for 340 (91.0%) of the 
374 women. Of these, 55 (16.2%) were smokers 
at the time of booking. Twenty-four were 
smoking between one and nine cigarettes per 
day (n=24 of 55, 43.6%) and thirty-one were 
smoking at least up to 10 cigarettes per day 
(n=31 of 55, 56.4%). 
Information on smoking in late pregnancy was 
available for 43 of the 55 smokers (78.2%) 
and only three (7.0%) stopped smoking 
during pregnancy. The prevalence of smoking 
during pregnancy or in the last trimester is 
not routinely known for all Irish pregnancies 
but rates of 12%, 15%, 16% and 19% have been 
reported for England, Northern Ireland, Wales 
and Scotland, respectively.24
There were no pregnancies with a documented 
history of alcohol abuse but three women had 
a documented history of drug abuse (prior and 
during pregnancy).
Previous pregnancy 
Seventy percent of mothers who experienced 
perinatal loss in 2016 had at least one previous 
pregnancy (gravida > 0; 264 of 373, 70.8%, 
unknown for one woman). Table 1.11 specifies 
gravida/parity for 373 of the 374 women who 
experienced perinatal loss in 2016. Nearly 
thirty percent (n=109, 29.2%) had never been 
pregnant before (gravida = 0). Of the 264 
women who had been pregnant (gravida > 0), 
most (n=147, 55.7%) had pregnancies exceeding 
24 weeks or 500g birthweight (gravida = parity, 
indicated by green shading). Over one third of 
these 264 mothers (n=91, 33%) experienced 
at least one pregnancy exceeding 24 weeks or 
500g birthweight and at least one pregnancy 
less than 24 weeks gestation and under 500g 
birthweight (gravida > parity > 0, indicated 
by yellow shading). Additionally, for 10.2% 
(n=26) these women’s previous pregnancies 
never exceeded 24 weeks gestation or 500g 
birthweight (gravida > parity = 0, indicated by 
orange shading).








0 1 2 3 4 5 6 7 8 9 Total
0 109 0 0 0 0 0 0 0 0 0 109
1 13 90 0 0 0 0 0 0 0 0 103
2 10 22 40 0 0 0 0 0 0 0 72
3 2 9 13 11 0 0 0 0 0 0 35
4 0 4 5 10 4 0 0 0 0 0 23
5 1 0 2 5 4 0 0 0 0 0 12
6 0 1 2 4 1 1 1 0 0 0 10
7 0 1 0 1 1 0 0 0 0 0 3
8 0 0 0 0 0 0 0 0 1 0 1
9 0 0 0 0 0 0 0 0 0 0 0
10 0 0 0 0 0 0 0 2 0 1 3
11 0 1 0 0 0 0 0 0 1 0 2
Total 135 128 62 31 10 1 1 2 2 1 373
Note: We refer to gravida and parity prior to the pregnancy ending in perinatal death in 2016. Green represents women with 
previous pregnancies that were all ≥24 weeks or ≥500g; yellow represents women who had experienced pregnancy ≥24 weeks 
or ≥500g and also pregnancy <24 weeks and <500g; and, orange represents women whose previous pregnancies were always 
<24 weeks gestation and <500g birthweight.
24 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and 
care of pregnant women and babies in Europe in 2010. May 2013. Available www.europeristat.com
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Of the 264 women who had a previous 
pregnancy, 79.5% (n=210) were reported 
to have had a previous pregnancy-related 
problem (unknown for 7 women). Caesarean 
section delivery was the most common 
previous pregnancy-related problem with 
nearly twenty percent of mothers (n=69, 
18.4%) having a previous caesarean section 
delivery (Table 1.12). Pre-term birth or mid-
trimester loss was the second most common, 
with (n=24, 6.4%) of mothers experiencing 
this in a previous pregnancy. Three or more 
miscarriages (n=21, 5.6%) was the third most 
common pregnancy-related problem in 
mothers who had a previous pregnancy. 











Previous caesarean delivery 60 (19.9) 61 (18.7) 63 (18.9) 71 (21.9) 69 (18.4)
Pre-term birth or mid-trimester loss 19 (6.3) 13 (4.0) 29 (8.7) 25 (7.7) 24 (6.4)
Three or more miscarriages 13 (4.3) 14 (4.3) 16 (4.8) 24 (7.4) 21 (5.6)
Infant requiring intensive care 3 (1.0) 5 (1.5) 14 (4.2) 13 (4) 11 (2.9)
Stillbirth 9 (3.0) 10 (3.1) 7 (2.1) 12 (3.7) 9 (2.4)
Baby with congenital anomaly 6 (2.0) 4 (1.2) 7 (2.1) 10 (3.1) 7 (1.9)
Pre-eclampsia 13 (4.3) 14 (4.3) 18 (5.4) 8 (2.5) 11 (2.9)
Post-partum haemorrhage requiring transfusion 6 (2.0) 3 (0.9) 4 (1.2) 5 (1.5) 5 (1.3)
Placental abruption 4 (1.3) 1 (0.3) 4 (1.2) 4 (1.2) 3 (0.8)
Neonatal death 11 (3.7) 9 (2.8) 6 (1.8) 3 (0.9) 5 (1.3)
Placenta praevia 1 (0.3) 1 (0.3) 2 (0.6) 1 (0.3) 2 (0.5)
Other 54 (17.9) 39 (12.0) 47 (14.1) 35 (10.8) 43 (11.5)
*Note: Percentage relates to total number of mothers who had a previous pregnancy (n = 264). 
In terms of parity, women who experienced 
perinatal loss in 2016 were broadly similar to 
the population of women who gave birth in 
2016, although there was an overrepresentation 
of women with at least three previous deliveries 
among those who experienced perinatal loss 
(Table 1.13). Comparison of the total perinatal 
mortality rate by parity confirmed the similarity 
of the rate between nulliparous women and 
multiparous women with one or two previous 
deliveries, whereas women with three or more 
previous deliveries had a 50% higher risk (Table 
1.14). 



















Nulliparous 186(41.8) 174 (37.6) 182 (38.7) 176 (38.3) 135 (36.2) 38.2%
Para 1 129 (29.0) 137 (29.6) 142 (30.2) 149 (32.4) 128 (34.3) 34.9%
Para 2 72 (16.2) 87 (18.8) 85 (18.1) 84 (18.3) 62 (16.6) 17.9%
Para 3+ 58 (13.0) 65 (14.0) 61 (13.0) 51 (11.1) 48 (12.9) 9.0%
Note: Values are shown as n(%) unless otherwise stated. 
25  Healthcare Pricing Office. Perinatal Statistics Report 2016. Dublin: Health Service Executive. [in press]
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Table 1.14: Comparing the relative risk of perinatal mortality by parity among mothers in 2016
Parity





Nulliparous 5.5 (4.6-6.5) 1.00 (reference) -
Para 1 5.7 (4.8-6.8) 1.04 (0.81-1.32) 0.771
Para 2 5.4 (4.1-6.9) 0.98 (0.72-1.32) 0.889
Para 3+ 8.3 (6.1-11) 1.50 (1.08-2.08) 0.016
Pre-existing medical problems
Information about pre-existing medical 
conditions was available for 347 of the 374 
mothers who experienced perinatal loss in 
2016 (92.8%). Over thirty percent of these 347 
women had a pre-existing medical problem 
(n=123, 35.4%). This represents an increase 
compared to the 31.2% rate in 2015. 
The most common type of pre-existing medical 
problems were the Psychiatric disorders with 
11.5% of mothers (n=40 of 347 women) suffering 
from conditions of this type (Table 1.15). This 
was followed by Endocrine disorders which had 
second the highest percentage of occurrence 
(n= 26, 7.5%). Gynaecological issues (captured 
under the label “other”) were also common 
among women, with 5.2% (n=18) reporting 
having a pre-existing medical problem of this 
type (including infertility, oncological issues 
and other disorders). Also under the “Other” 
category a wide range of problems were 
captured, such as asthma, musculoskeletal and 
hepatic issues. 











Psychiatric disorder 19 (4.5) 25 (5.7) 34 (7.6) 32 (7.2) 40 (11.5)
Endocrine disorder 21 (5.0) 17 (3.9) 30 (6.7) 24 (5.4) 26 (7.5)
Diabetes 8 (1.9) 13 (3.0) 16 (3.6) 16 (3.6) 8 (2.3)
Hypertension 22 (5.2) 7 (1.6) 10 (2.2) 13 (2.9) 9 (2.6)
Cardiac disease 6 (1.4) 11 (2.5) 9 (2) 6 (1.3) 6 (1.7)
Haematological disorder 6 (1.4) 3 (0.7) 8 (1.8) 5 (1.1) 9 (2.6)
Renal disease 9 (2.1) 6 (1.4) 7 (1.6) 4 (0.9) 3 (0.9)
Inflammatory disorder 7 (1.7) 3 (0.7) 6 (1.3) 17 (3.8) 3 (0.9)
Epilepsy 5 (1.2) 4 (0.9) 1 (0.2) 5 (1.1) 1 (0.3)
Other 103 (24.3) 92 (20.9) 107 (23.9) 65 (14.6) 62 (17.9)
Any pre-existing medical problem 169 (40.0) 146 (33.2) 179 (40.0) 139 (31.2) 123 (35.4)
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Delivery
Labour was induced in 59.6% of women who 
experienced a stillbirth (n=149 of 250) and 
16.1% of those who experienced a neonatal 
death (n=20 of 124). A caesarean section was 
the planned mode of delivery for 14.6% of the 
women who experienced a stillbirth (n=36 of 
246; unknown for four cases) and 17.2% of the 
women who experienced an early neonatal 
death (n= 21 of 122; unknown for two cases).
The type of care received at delivery was known 
for all of mothers who experienced perinatal 
loss (n=374). The vast majority of the babies 
(n=368, 98.4% of 374) were delivered under 
obstetric-led care which is the predominant 
model of care in Ireland. Six babies (1.6%) were 
born before arrival at the maternity unit. 
Presentation at delivery was known for 98.7% of 
mothers who experienced perinatal loss (n=369 
of 374). Nearly half of presentations at delivery 
were vertex presentations (n=186 of 374, 49.7%), 
approximately 11.8% were breech presentation 
(n=44 of 374) and in ten cases, the presentation 
was compound (n=10).
Mode of delivery was known for 99.4% (n=372) 
of mothers who experienced perinatal loss 
(Table 1.16). Spontaneous vaginal cephalic 
delivery was the mode of delivery for over 
sixty-one percent of stillbirths (n=153 of 249, 
61.4%) and for approximately forty percent of 
the babies who died in the early neonatal period 
(n=49 of 123, 39.8%). Over forty percent of the 
deliveries in cases of neonatal death involved 
caesarean section (42.3%), usually pre-labour 
(25.2%). Approximately twenty percent of 
stillbirths involved caesarean section (19.3%), 
again predominantly pre-labour (16.9%). Among 
stillbirths delivered by caesarean section, over 
fifty-two percent of the mothers (n=25 of 48, 
52.1%) had a previous caesarean delivery. 
In comparison to the proportion of all births 
occurring with assisted breech delivery in 2016 
(0.5%), this type of delivery is relatively more 
common in stillbirths (4.4%) and neonatal 
deaths (5.7%). 
Table 1.16: Mode of delivery for mothers who experienced perinatal loss in 2016
Stillbirths  
(N=250)
Neonatal deaths  
(N=123) All births
26
Spontaneous Vaginal Cephalic 154 (61.6) 49 (39.8) Vaginal birth
52.2%Spontaneous Vaginal Breech 34 (13.6) 12 (9.8)
Pre-labour Caesarean Section 42 (16.8) 31 (25.2) Caesarean section
32.6%Caesarean Section 6 (2.4) 21 (17.1)
Assisted Breech 11 (4.4) 7 (5.7) 0.5%
Ventouse 1 (0.4) 2 (1.6) 11.1%
Forceps 2 (0.8) 1 (0.8) 3.6%
Note: Values are n(%) unless otherwise stated. One early neonatal death born by vaginal delivery, although type not specified as 
this was a baby born before arrival to maternity unit. 
Emergency caesarean section delivery was 
the most common type of caesarean section 
delivery in 2016, accounting for 49% of the 
100 cases of perinatal death delivered by 
caesarean section (n=49 of 100). Over 35% 
percent were categorised as elective caesarean 
sections (n=35 of 100) and 16% were urgent 
(n=16 of 100). Elective caesarean delivery was 
the most common type of caesarean delivery 
in stillbirths (n=24 of 48, 50%) and emergency 
caesarean delivery was the most common type 
of caesarean delivery in early neonatal deaths 
(n=30 of 52, 57.7%). 
26 Healthcare Pricing Office. Perinatal Statistics Report 2016. Dublin: Health Service Executive. [in press]
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Infant characteristics
The findings presented below are based on 
stillbirths and early neonatal deaths born with 
a birthweight ≥500g or having achieved a 
gestational age ≥24 weeks.
Sex 
There were four perinatal deaths for which the 
sex of the baby was indeterminate (Table 1.18). Of 
the 371 perinatal deaths where sex was reported, 
57.1% were male (n=212). In the overall population 
of births in 2016, 51.3% were male and 48.7% 
female.27 Male babies outnumbered female babies 
among stillbirths and early neonatal deaths.
Table 1.18: Sex of baby in stillbirths and neonatal deaths in 2016
Stillbirths n (%) Early neonatal deaths n (%)
Male 133 (53.8) 79 (63.7)
Female 111 (44.9) 44 (35.5)
Indeterminate 3 (1.2) 1 (0.8)
Note: Sex of the infant was not reported for three cases of stillbirth.
Multiple births 
There was an association between perinatal death and multiple pregnancies. There were 33 
perinatal deaths from multiple births, making up 8.8% of all perinatal deaths in 2016 (Table 1.19). 
This is approximately 2.5 times the proportion of multiples among all births in 2016 (3.8%).27 
27 Healthcare Pricing Office. Perinatal Statistics Report 2016. Dublin: Health Service Executive. [in press]
Table 1.19: Perinatal deaths from singleton and multiple births
Perinatal Deaths n(%) Stillbirths n(%) Early Neonatal Deaths n(%) All births27 n(%)
Singleton 341 (91.18%) 233 (93.2) 108 (87.1) 61,333 (96.2%)
Twins 31 (8.29%) 15 (6) 16 (12.9)
2,415 (3.8%)Triplet 1 (0.27) 1 (0.4) 0 (0)
Other Multiple Births 1 (0.27) 1 (0.4) 0 (0)
Total 374 (100%) 250 (100%) 124 (100%) 63,748 (100%)
Level of care for mothers post-delivery 
For women who experienced perinatal loss in 
2016, 5.4% (n=20 of 370, unknown for 4 cases) 
were admitted to a high dependency unit (HDU) 
and 1.8% (n=7 of 370, unknown for 4 cases) were 
admitted to an intensive care unit (ICU). Similar 
admission rates were reported for the years 
between 2012 and 2015 (Table 1.17). Admission 
to HDU for the mother was more common in 
cases of early neonatal death while the opposite 
was recorded for admission to ICU where all the 
mothers admitted related to cases of stillbirth. 
Deliveries by emergency caesarean section were 
associated with higher levels of admission to both 
the HDU (14.6%, n=7 of 48 cases of this type of 
caesarean section), and ICU (8.3%, n=4 of 48). 





















Admitted to HDU 29 (6.5) 29 (6.4) 25 (5.4) 41 (9.1) 20 (5.4) 9 (3.7) 11 (8.9)
Admitted to ICU 7 (1.6) 6 (1.3) 16 (3.4) 9 (2.0) 7 (1.8) 7 (2.8) 0 (0)
Note: Values are n(%) unless otherwise stated. Admission data unknown for four women in 2016. 
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The 33 perinatal deaths from multiple births 
comprised 17 stillbirths and 16 early neonatal 
deaths. The majority (n=12, 75%) of the 16 early 
neonatal deaths from multiple births were due 
to respiratory disorders, most often severe 
pulmonary immaturity, the remaining four 
deaths were due to major congenital anomalies 
(n=3, 18.8%) and gastro-intestinal disease (n=1, 
6.3%). The main causes of the 17 stillbirths from 
multiple births were major congenital anomalies 
(n=8, 47.1%), specific placental conditions (n=4, 
23.5%) and mechanical causes (n=2, 11.8%). 
Other causes of death identified include specific 
fetal conditions and infection (each of these 
causes n=1, 5.9%). The main cause of death was 
unexplained for one stillbirth (5.9%).
Chorionicity was reported for 31 of the 33 
perinatal deaths from multiple births. The vast 
majority were cases with dichorionic diamniotic 
(n=26, 78.8%) and the remaining cases were 
monochorionic diamniotic (n=5, 15.2%). 
There were 25 cases where one twin died, three 
pairs of twins where both twins died, one case 
where one triplet died and one where one 
quadruplet died, indicating a total of 33 perinatal 
losses involving 30 pregnancies. It was reported 
that seven of these multiple pregnancies were 
the result of a fertility treatment (7 of 30 
pregnancies, 23.3%).
Gestation 
Almost seventy percent of perinatal deaths in 2016 were associated with delivery before 37 weeks 
gestation (n=258 of 374, 69.0%). This was the case for 66.8% of stillbirths (n=167 of 250) and 73.4% 
of early neonatal deaths (n=91 of 124). A higher proportion of extremely pre-term delivery, i.e. delivery 
at 22-27 weeks gestation, was more often associated with cases of early neonatal death than cases 
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Birthweight 
The most represented birthweight in cases of perinatal death was in the range 500-999 grams 
(n=101 of 374, 27%). This was particularly evident for early neonatal deaths than stillbirths (Figure 
1.10). In over seventy percent of perinatal deaths (n=270, 72.2%) the birthweight was less than 2,500 
grams. For stillbirths, 70.8% had a birthweight below 2,500g (n=177 of 250) and 75% of neonatal 
deaths (n=93 of 124) also registered weight below this value. 


































An increased risk of perinatal death has been 
associated with failure of fetal growth in utero. 
We have produced two charts to highlight 
this issue in relation to the stillbirths and early 
neonatal deaths that occurred in Ireland in 
2016. To do so, we used the Gestation Related 
Optimal Weight (GROW) software and 
coefficients derived from the multiple regression 
analysis of data on 11,072 births in six maternity 
units in Dublin, Galway, Limerick and Belfast in 
2008-2009.28
The regression analysis determined the Term 
(i.e. 40 weeks) Optimal Weight (TOW) in Ireland 
to be 3,490.7g. The normal range (i.e. the range 
from the 10th centile weight to the 90th centile 
weight) around the TOW was then calculated 
and the recommended proportionality growth 
function was applied to the TOW, the 10th 
centile term weight and the 90th centile term 
weight in order to determine the optimal weight 
and normal range at all gestations (21-44 weeks 
for stillbirths and early neonatal deaths in 
Ireland in 2016). These steps are described in 
detail in the GROW documentation.29 
28 Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. 
The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7 

























The optimal weight and normal range for 
all gestations are plotted with the actual 
birthweights of the stillbirths in Figure 1.11 and 
with the birthweights for cases of early neonatal 
death in Figure 1.12. For stillbirths across all 
gestational ages, a high proportion were 
below the lower limit of the normal range (10th 
centile). In cases of early neonatal death, the 
birthweight was often below the normal range 
for births after 32 weeks gestation. However, 
low birthweight was observed less often than 
for cases of stillbirth.
Figures 1.11 and 1.12 have the limitation of plotting 
actual birthweights against the optimal weight 
and normal range adjusted only for gestational 
age. There is no adjustment for other factors 
affecting birthweight, namely, maternal height, 
weight, parity and ethnic group and infant sex. 
The use of centiles customised for maternal 
and infant characteristics affecting birthweight 
identifies small babies at higher risk of mortality 
better than population centiles.30 Small-for-
gestational-age (SGA) refers to birthweights 
below the 10th centile and severely SGA refers 
to birthweights less than the 3rd centile.31
30 Clausson B, Gardosi J, Francis A, Cnattingius S. Perinatal outcome in SGA births defined by customised versus population–based 
birthweight standards. BJOG 2001;108:830–4.
31  Royal College of Obstetrics and Gynaecologists. The investigation and management of the small-for-gestational age fetus.  
RCOG Green Top Guideline 2013 (No.31). Available at: www.rcog.org.uk/files/rcog-corp/22.3.13GTG31SGA_ExecSum.pdf
Figure 1.11: Optimal birthweight and normal range compared to actual birthweights of stillbirths, 2016 
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Customised birthweight centiles were derived 
using the GROW software.32 There was missing 
data for maternal height and weight with one or 
both unknown for 13.9% of the mothers (n=52). 
For these cases, we used the median height 
and weight of the mothers with complete data. 
The GROW software also provides estimated 
customised birthweight centiles in cases with 
missing data. Ultimately, customised birthweight 
centiles were calculated for all 374 perinatal 
deaths.
The distribution of customised birthweight 
centiles at all gestations is illustrated for 
stillbirths in Figure 1.13 and for early neonatal 
deaths in Figure 1.14. At all gestations, there were 
cases spanning the full range of birthweight 
centiles (i.e. 0-100th) but there was a clear 
overrepresentation of cases below the median 
and far more at or near centile zero than would 
be expected in the population of all births.
32 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.7.6.5(IE), 2015 Gestation Network, www.gestation.net
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Figure 1.13: Distribution of customised birthweight centiles for stillbirths, 2016 
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Table 1.20 details the number and percentage 
of stillbirths and early neonatal deaths within 
specific ranges of customised birthweight 
centiles. Low birthweight was associated with 
both groups but particularly with stillbirths. 
Almost half (47.2%) of all stillbirths were 
classified as severely SGA (<3rd customised 
birthweight centile) and 60% were SGA (<10th 
customised birthweight centile) compared to 
25.0% and 33.9% of the cases of early neonatal 
death, respectively. SGA may be more prevalent 
among stillborn babies because they may 
have died some days or weeks before being 
delivered. We do not record whether there was 
evidence of maceration in cases of stillbirth 
but there was support for this hypothesis. The 
customised birthweight centile of the stillborn 
baby was lower when there was more than 
one week between confirmation of death and 
delivery. 
Table 1.20: Distribution of customised birthweight centiles, 2016
Centile Stillbirth (N=250) Neonatal death (N=124)
< 3rd 118 (47.2) 31 (25.0)
< 10th 150 (60.0)* 42 (33.9)*
10-49th 53 (21.2) 44 (35.5)
50-89th 33 (13.2) 20 (16.1)
90th+ 14 (5.6) 18 (14.5)
Note: Values are n (%) unless otherwise stated. *Includes cases from the category <3rd Centile. 
Table 1.21: Distribution of customised birthweight centiles of perinatal deaths due and not due to major 
congenital anomaly, 2016
Centile Stillbirth (N=250) Neonatal death (N=124)
Cause of death: major congenital anomaly Cause of death: major congenital anomaly
Yes (n=78) No (n=172) Yes (n=67) No (n=57)
< 3rd 51 (65.4%) 67 (39.0%) 28 (41.8%) 3 (5.3%)
< 10th 58 (74.4%) 92 (53.5%) 35 (52.2%) 7 (12.3%)
10-49th 7 (9.0%) 46 (26.7%) 17 (25.4%) 27 (47.4%)
50-89th 4 (5.1%) 29 (16.9%) 4 (6.0%) 16 (28.1%)
90th+ 9 (11.5%) 5 (2.9%) 11 (16.4%) 7 (12.3%)
Note: Values are n (%) unless otherwise stated. *Includes cases from the category <3rd Centile.
Cases of stillbirth and early neonatal death were 
at significantly lower birthweight centiles when 
the cause of death was attributed to major 
congenital anomaly (Table 1.21). Two thirds of 
the 78 stillbirths due to congenital anomaly 
(n=51, 65.4%) were severely SGA in comparison 
to 39% of the stillbirths due to other causes 
(n=67, 39.0%). Similarly, 42% of the 67 early 
neonatal deaths due to congenital anomaly 
(n=28, 41.8%) were severely SGA compared 
to just five percent (n=3, 5.3%) of the 57 early 
neonatal deaths due to other causes.
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Data on diagnosis of fetal growth restriction 
(FGR) were recorded for 363 of the 374 
perinatal deaths. A diagnosis of FGR was 
reported for 69 (19.0%) of the 363 deaths, 55 
(22.6%) stillbirths and 14 (11.7%) early neonatal 
deaths. An antenatal diagnosis of FGR (as 
opposed to diagnosis based on observation at 
delivery or post-mortem) was reported for 54 
perinatal deaths (14.9%), 41 stillbirths (16.9%) 
and 13 early neonatal deaths (10.8%). 
For stillbirths and cases of early neonatal death 
that were severely SGA (<3rd customised 
birthweight centile), approximately 30% had 
an antenatal diagnosis of FGR (Table 1.22). The 
level of antenatal diagnosis of FGR was lower, 
at approximately one in four, for stillbirths and 
cases of early neonatal death that were SGA 
(<10th customised birthweight centile). 
Diagnosis of fetal growth restriction (FGR)
Table 1.22: Antenatal diagnosis of fetal growth restriction (FGR) for small-for-gestational-age (SGA) and 
severely SGA perinatal deaths in 2016
Antenatal diagnosis of FGR 
n of N (%)
Stillbirth
Severely SGA (<3rd centile) 35 of 114* (30.7)
SGA (<10th centile) 39 of 145* (26.9)
Neonatal death
Severely SGA (<3rd centile) 9 of 31 (29.0)
SGA (<10th centile) 9 of 40* (22.5)
* Note: SGA cases include severely SGA cases; FGR diagnosis unknown for four severely SGA stillbirths, for five SGA 
stillbirths and for two SGA cases of early neonatal death. 
•  Recommendation: Improved antenatal 
detection of fetal growth restriction (FGR) 
with timely delivery is a preventative 
strategy to reduce perinatal mortality. 
–  Again, we recommend the generation of 
customised birth weight centile charts 
for every woman during pregnancy and 
concomitantly, staff should be trained in 
risk assessment, plotting symphysial fundal 
height (SFH) and scan weight estimates in 
order to reduce stillbirths in Ireland.
–  Based on feedback to the NPEC, other 
methodologies could be considered. A 
multidisciplinary working group should 
be developed to address a national 
standardised approach to the detection 
of FGR. A national approach should also 
evaluate the use of a standard growth curve 
across all Irish maternity units. The Institute 
of Obstetrics and Gynaecology would be 
well placed to facilitate this working group.
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Investigations to determine the cause of death
Autopsy
Current practice guidelines recommend 
that parents should be offered a full post-
mortem examination of the stillborn infant 
to help explain the cause of death.33 Data on 
autopsy uptake was reported for 372 of the 
374 perinatal deaths, of which 47.8% (n=178) 
underwent an autopsy. The proportion of 
autopsy uptake in 2016 was slightly lower than 
the 50.4% reported in 2015 but is in line with 
the 48.3% reported in 2014. The trend in the 
perinatal autopsy rate is illustrated in Figure 1.15. 
The autopsy uptake rate has been higher for 
stillbirths than in cases of early neonatal death, 
albeit by a smaller margin in recent years.
In Ireland in 2016, an autopsy was undertaken 
following 54.2% of stillbirths (n=135 of 249, 
unknown for one case) and 35.0% of early 
neonatal deaths (n=43 of 123, unknown for 
one case), see Figure 1.17. These figures are 
higher than in the UK as a whole in 2015 (full 
autopsy for 44.2% of stillbirths and 24% of 
early neonatal deaths),34 whereas the autopsy 
rate in Northern Ireland in 2014 was higher for 























Figure 1.15: Autopsy uptake percentage, 2011-2016
33  Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of Obstetricians and 
Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.
34 Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the MBRRACE-UK collaboration. 
Perinatal Mortality Surveillance Report UK Perinatal Deaths for births from January to December 2014. Leicester: The Infant Mortality and 
Morbidity Group, Department of Health Sciences, University of Leicester. 2016.






















Total number of perinatal deaths in unit (≥500g or ≥24 weeks)
Unit-specific rate Overall rate      95% Confidence interval
Figure 1.16: Funnel plot of autopsy uptake in the 19 Irish maternity units in 2016 
Note: Autopsy uptake unknown for two cases of perinatal death; 40% refers to rate in two units  
(represented by overlapping diamonds).
The variation in the rate of autopsy across the 19 maternity units in 2016 is illustrated in 
the funnel plot (Figure 1.16). This may reflect variation in access to dedicated perinatal 
pathology services across units. There was some variation found across the four large 
maternity units, with rates of 42%, 46%, 48% and 69% being found across the four units. 
Figure 1.17 details the autopsy-related steps 
taken following the 374 perinatal deaths in 
2016. A total of 178 autopsies were performed 
on cases of perinatal death and there were 194 
cases that did not receive an autopsy (unknown 
for 2 cases). 
Thirty-four of the deaths became coroner cases 
(9.2% of 372 cases for which autopsy status was 
known) and, at the time data were reported 
to the NPEC, the maternity unit had received 
the autopsy report from the coroner’s office in 
16 of these cases (47.1%). For the 336 deaths 
which were not coroner cases, there were 142 
autopsies undertaken (in four perinatal deaths, 
it was unknown if they were coroner cases).
Over half of the perinatal deaths (51.9%) did not 
receive an autopsy (n=194). For the majority 
of these cases an autopsy was offered and 
presumably declined by parents (n=172, 88.7% 
of the cases without autopsy). This is a slight 
increase in the rate of autopsy offer reported 
in 2015 (84%). Such an offer was made more 
often in cases of stillbirth (100 of 172 autopsies 
offered, 58.1%) than for early neonatal deaths 
(72 of 172, 41.2%). Consequently, in 2016 of 
the 372 cases where data on autopsy uptake 
was reported, there were 22 perinatal deaths 
for which an autopsy was not offered (n=22 
of 372, 5.9%). This represents a slightly lower 
proportion than in 2015, when 34 (of 452, 7.5%) 
perinatal deaths were not offered an autopsy 
(autopsy uptake unknown for four cases). 
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Figure 1.17: Flowchart outlining autopsy-related steps taken after 374 perinatal deaths in 2016
Note: Autopsy unknown for one stillbirth and one early neonatal death. 
The decision not to offer to undertake an autopsy may be influenced by the clinical scenario and 
the antenatal diagnosis. There was evidence to support this in relation to major congenital anomaly. 
The proportion of cases not offered an autopsy was higher if the perinatal death was due to a major 
congenital anomaly than if it the death was due to another cause (Table 1.23). 
Table 1.23: Uptake and offer of autopsy of perinatal deaths due and not due to major congenital anomaly, 2016
Autopsy Stillbirth (N=235 of 236) Neonatal death (N=123 of 124)
Cause of death: major congenital anomaly Cause of death: major congenital anomaly
Yes (n=78) No* (n=171) Yes (n=66) No* (n=57)
Performed 28 (35.9%) 107 (62.6%) 21 (31.8%) 22 (38.6%)
Offered 40 (51.3%) 60 (35.1%) 39 (59.1%) 33 (57.9%)
Not offered 10 (12.8%) 4 (2.3%) 6 (9.1%) 2 (3.5%)
Note: Data on whether autopsy was performed and/or offered was incomplete for one case of stillbirth and one case of early 
neonatal death. Values are n (%) unless otherwise stated
•  Recommendation: Further research exploring factors impacting on autopsy rates, 
particularly in the case of neonatal deaths, is warranted. 
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•  Recommendation: Anonymised placental histology reports on perinatal death 
should be submitted to the NPEC as part of this audit: this would facilitate 
standardised interpretation and classification of placental conditions.
Placental examination 
The value of placental examination in 
determining cause of perinatal death is well 
documented.36 In 2016, placental histology 
examinations were conducted for almost all 
stillbirths (n=242 of 250 stillbirths, 96.8%) and 
for 93.4 % of early neonatal deaths (n=114 of 
122 of early neonatal deaths, unknown for two 
cases). Thus, there has been a slight reduction 
in the rate of placental histology examination 
for stillbirths from 99.0% in 2015 to 96.8% 
in 2016 but an increase in this rate for early 
neonatal deaths (from 92.0% in 2015 to 93.4% 
in 2016). In 2015, lower levels of placental 
histology examinations were reported for 
stillbirths in the UK as a whole (88.8%).37
Specific placental conditions 
Abnormal placental findings have been 
classified in line with recommendations 
from the publication from the international 
consensus meeting of pathology.38 These 
are presented under the following broad 
categories: Maternal vascular malperfusion, 
Fetal vascular malperfusion, Cord pathology, 
Cord pathology with distal disease, Delayed 
villous maturation, Chorioamnionitis, Villitis, 
Fetal Vasculitis and other. 
Of the 242 stillbirths and 114 early neonatal 
deaths for which placental examinations were 
conducted (placental histology unknown for 
two early neonatal cases), specific placental 
pathology was present in 160 (66.1%) of 
stillbirths and 68 (59.7%) of early neonatal 
deaths (Table 1.24). More than one placental 
condition was present for some cases. 
Specific placental conditions were generally 
more prevalent among stillbirths than among 
cases of early neonatal death. In the case of 
stillbirths, conditions within the maternal and/
or fetal vascular malperfusion categories were 
most commonly reported (n=73, 30.2% and 
64, 26.4% respectively).
Submission of anonymised placental histology 
reports to the NPEC as part of this audit 
would facilitate standardised interpretation 
and classification of placental conditions at 
national level. 
36 Korteweg FJ, Erwich JJ, Timmer A, van der Meer J, Ravise JM, Veeger NJ, Holm JP. Evaluation of 1025 fetal deaths: proposed diagnostic workup. 
Am J Obstet Gynecol 2012 206:53.e1-53.e12
37 Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the MBRRACE-UK collaboration. 
Perinatal Mortality Surveillance Report UK Perinatal Deaths for births from January to December 2014. Leicester: The Infant Mortality and 
Morbidity Group, Department of Health Sciences, University of Leicester. 2016.
38 Khong TY, Mooney EE et al (2016). Sampling and definition of placental lesions. Arch Pathol Lab Med 2016 Jul;140 (7):698-713
Table 1.24: Placental histology findings for stillbirths and early neonatal deaths, 2016 
Stillbirth n (%)  
(n=242)
Neonatal death n (%)  
(n=114)
Maternal vascular malperfusion 73 (30.2) 27 (23.7)
Fetal vascular malperfusion 64 (26.4) 15 (13.2)
Cord pathology 44 (18.2) 11 (9.6)
Cord pathology with distal disease 6 (2.5) 0 (0)
Delayed villous maturation* 11 (4.5) 3 (2.6)
Chorioamnionitis 20 (8.3) 46 (40.4)
Villitis 2 (0.8) 1 (0.9)
Other placental condition* 28 (11.6) 10 (8.8)
Any placental condition 160 (66.1) 68 (59.6)
Note: More than one placental condition was present for some cases. 
*Includes Placental disease due to massive perivillous fibrin deposition. 
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Other examinations performed 
External examinations were performed for 
over forty percent of the 374 perinatal deaths 
in 2016 (n=154, 41.3%) compared to forty 
seven percent (47.8%) in 2015 (Table 1.25). 
Performing X-Ray, similarly to the trend in 
previous years, has continued to increase 
as it was reported to have been performed 
slightly more often following perinatal 
death in 2016 (34.0%) than in 2015 (33.6%). 
Computerised tomography scans (CT scan) 
and magnetic resonance imaging (MRI) tests 
were rarely undertaken. External examination 
and X-ray were carried out more often 
following cases of stillbirth in 2016 than for 
cases of early neonatal death. 



















External 247 (53.3) 211 (45.0) 219 (47.8) 154 (41.3) 110 (44) 44 (35.8)
X-Ray 118 (25.5) 147 (31.3) 154 (33.6) 127 (34) 94 (37.6) 33 (26.8)
CT scan 7 (1.5) 1 (0.2) 0 2 (0.5) 2 (0.8) 0 (0)
MRI 0 (0.0) 2 (0.4) 1 (0.2) 0 (0.8) 0 (0) 3 (2.4)
Note: Values are n (%) unless otherwise stated. CT=Computerised tomography, MRI=magnetic resonance imaging. Data on 
whether other examination was performed was missing for one case of early neonatal death. 
Cytogenetic analysis is an important 
investigation in the diagnosis of 
chromosomal abnormalities. Some 
abnormalities are potentially recurrent and 
can be tested for in future pregnancies.39 
In the event of a chromosomal disorder, a 
specific question on the NPEC Perinatal 
Death Notification form (Appendix E) 
asks how the diagnosis was made. A 
chromosomal disorder was the most 
commonly reported major congenital 
malformation causing death in 2016 (67 
perinatal deaths; 50 stillbirths and 17 early 
neonatal deaths). In almost seventy percent 
of these cases (n=46, 68.7%), the diagnosis 
was made by cytogenetic analysis (n=33 
stillbirths, 66% of the 50; n=13 neonatal 
deaths, 76.5% of 17). 
Genetic investigation in chromosomal disorders 
39 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of Obstetricians and 
Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.
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2.  Invited Commentary: Reducing the Burden of 
Intrapartum Fetal Deaths 
Intrapartum fetal death (IPD), the death of a 
fetus during labour is a tragic and traumatic 
outcome of pregnancy (1). Worldwide there is a 
substantial healthcare burden associated with 
IPD and it is estimated that approximately half of 
the 2.6 million stillbirths that occur each year are 
intrapartum (2). The number of IPDs occurring 
in high income countries may be small (0.3-
0.7/1000 births) but each one leaves a profound 
impact, on both the parents and the involved 
healthcare professionals (2-4).
It is now accepted that the intrapartum death 
rate of an individual country or maternity unit is 
reflective of the care provided to both mothers 
and infants in labour, and that access to and 
utilisation of high quality, evidence-based 
intrapartum care is one way to further reduce 
intrapartum death rates (2, 3, 5-8). In-depth 
analysis of these cases will identify positive 
aspects of patient care, as well as point to areas 
of care that need to be improved upon (9).
The National Perinatal Epidemiology Centre 
(NPEC) collects and audits anonymised data on 
all stillbirths and neonatal deaths that occur each 
year in the Republic of Ireland (ROI). The dataset, 
which now contains over 400 discrete variables, 
represents the most complete and best quality 
data pertaining to all perinatal deaths in the ROI. 
This dataset provides the data for this review, 
which is based on analysis of data from 2011-2016. 
Intrapartum Fetal Deaths in Ireland 
(2011-2016) 
For the past number of years the IPD rate in 
the Republic of Ireland has remained static (10). 
There were 118 intrapartum deaths from 2011 to 
2016 giving an overall IPD rate of 0.28 per 1000 
births. When this is corrected for infants with a 
major congenital malformation, the rate is 0.16 
per 1000 births.
Maternal Characteristics (n=118)
With respect to the 118 mothers, the mean 
maternal age was 31 years and the majority 
(98/118, 83.1%) were white Irish. At their booking 
visit 27/118 (23%) mothers smoked with over 
half (15/27, 55.5%) continuing to do so for the 
remainder of their pregnancy. The median 
BMI was 24.45kg/m2 but 47 mothers (40.5%) 
were either overweight or obese. Gestational 
age at booking was known for 101/118 mothers 
with 29/101 (28.7%) mothers booking outside 
the World Health Organisations (WHO) 
recommended gestational age for booking of 
less than 16 weeks. 
Labour commenced spontaneously in 69.5% 
(82/118) of mothers; 28.2% (34/118) had their 
labours induced while the remaining 2 underwent 
a pre-labour emergency CS. Table 2.1 details the 
mode of delivery for the 118 mothers in this cohort. 
Table 2.1 Mode of delivery in intrapartum fetal deaths in Ireland: 2011 - 2016




AB delivery 34 (28.8)
CS pre-labour 2 (1.7)
CS after the onset of labour 12 (10.2)
Total 118 (100)
SVD Spontaneous vaginal delivery, AB delivery Assisted Breech Delivery, CS Caesarean Section
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Fetal Characteristics (n=99)
The majority (110/118, 93.2%) of pregnancies 
were singleton pregnancies and there were more 
male infants (59) than female infants (57) in the 
cohort. Two IPDs were associated with infants of 
indeterminate sex. Gestational age of the infants 
who died was as expected with 2 distinct peaks 
occurring at opposite ends of the gestational age 
spectrum: forty-two deaths occurred less than 
27+6 weeks of gestational age with a further 
forty-seven deaths occurring after 37 weeks 
of gestational age. Once infants with a major 
congenital malformation were excluded, however, 
the predominant gestational age range for the 
infants who died during labour was before 27+6 
(39/65, 60%). The median birth weight for all 
infants was 1570g (range 320g – 4560g).
Normally Formed Intrapartum 
Deaths (n=65)
Of the 65 normally formed infants, 15 (26.8%) 
had a customised birth weight less than the 
10th percentile for gestational age. Growth 
restriction was suspected antenatally for just 1 
of these infants. Overall 16 infants were normally 
formed and had a gestational age over 37 weeks. 
When customised birth weight percentiles were 
calculated for these infants 4/16 (25%) measured 
less than the 10th percentile. This was not 
suspected antenatally for any of these infants. 
Postnatal investigations
National and most international guidance 
now recommends the use of post-mortem 
examination and placental histology in all cases 
of stillbirth (11-13). In addition in the ROI any 
suspicious or “unnatural” death by law should be 
at the very least reported to the local Coroner. 
This includes all unexpected intrapartum deaths 
(11). Between 2011-2016, the post-mortem rate 
was 40.7% with a further 58.5% of parents 
being offered a post-mortem examination 
and declining. Coroner directed post-mortem 
examinations were conducted in 16.1% of cases. 
Post-mortem examinations were conducted on 
31/65 (47.7%) of the normally formed infants. 
Placental histology was available for 93.2% of 
IPDs. The NPEC does not collect data on whether 
cases were referred to the Coroner or not or 
why parents chose to decline a post-mortem 
examination for their infant.
Causes of death
Table 2.2 lists the main causes of death for all 
intrapartum deaths and I will now discuss some 
of these deaths in as much detail as the dataset 
allows. In total, 53/118 infants were diagnosed 
with a major congenital malformation and for 
all but one this was the documented cause of 
death. One infant was found to have Trisomy 
21 on postmortem but the main cause of death 
reported to NPEC was severe chorioamnionitis. 
Chorioamnionitis was reported as the main cause 
of death in 23 of the remaining infants. With 
the exception of two infants, all were born at a 
gestational age of less than 28 weeks. The first of 
the term infants died at 41 weeks of gestational 
age following a ventouse delivery. This was the 
infant that at postmortem was found to have 
trisomy 21. The second of these infants died 
following an induction of labour and ventouse 
delivery at 41+5 weeks gestational age. A hospital 
post-mortem examination was performed, and 
the cause of death was reported as severe 
chorioamnionitis and meconium aspiration with 
ensuing asphyxia. It was impossible to ascertain 
if chorioamnionitis was suspected during these 
mothers’ labours or not.
Antepartum haemorrhage ( APH) from a 
placental abruption was another relatively 
common cause of death, accounting for ten 
infants’ deaths. Two infants died at term; the 
others were all less than 28 weeks of gestational 
age. One term infant was delivered by forceps 
after an induced labour at 37+6 weeks of 
gestation. A post-morterm examination was not 
undertaken but placental histology agreed with 
the clinical diagnosis of placental abruption. The 
second term infant was born via emergency 
CS after the onset of labour at 40 weeks of 
gestational age. This was a male infant , weighing 
3355g at birth and this infant had a post-mortem 
examination conducted.
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Intrapartum asphyxia accounted for ten of the 
intrapartum deaths. Coroner’s Post-mortems 
were carried out in seven of the cases, a hospital 
post-mortem in one case and in the remaining 
two cases parents were offered post- mortem 
examinations but declined. The majority, (7/10) 
had some other contributing condition: Uterine 
rupture, premature prelabour rupture of the 
membranes (two cases), cord accident, placental 
lesion, maternal amniotic fluid embolism and fetal 
growth restriction. 
With respect to the remaining cases, seven 
deaths were unexplained. Post-mortem 
examinations were conducted in six of the seven 
unexplained cases. A post-mortem was offered 
but declined by the parents in the seventh case. 
At the time of analysis one post-mortem report 
had not been entered into the dataset.
Table 2.2 Intrapartum main cause of death: 2011 - 2016
Cause of Death Gestational Age at Delivery
Less than 32 
weeks




Major Congenital Malformation 8 (15.3%) 17 (32.7%) 27 (52%) 52 (100%)
Chorioamnionitis 21 (91.3%) 0 2 (8.7%) 23 (100%)
APH from placental abruption 8 (80%) 0 2 (20%) 10 (100%)
Intrapartum Asphyxia 3 (30%) 0 7 (70%) 10 (100%)
Unexplained 2 (33.3%) 0 4 (66.7%) 6 (100%)
Specific placental 2 (40%) 0 3 (60%) 5 (100%)
Mechanical 2 (66.6%) 0 1 (33.3%) 3 (100%)
Cord accident 0 1 (100%) 0 1 (100%)
APH from placenta praevia 2 (100%) 0 0 2 (100%)
Specific fetal, acute TTTS 0 1 (100%) 0 1 (100%)
Associated Obstetric Factors (PPROM) 4 (100%) 0 0 4 (100%)
Unexplained - PM Pending 0 0 1 1 (100%)
The corrected intrapartum fetal death rate of 0.12 
per 1000 births in the ROI compares favourably 
with that of the United Kingdom (0.35) and 
other high- income countries (2, 14). In addition, 
the intrapartum death rate for normally formed 
infants greater than 37 weeks gestation is 0.04 
per 1000 births. It is difficult to draw any real 
conclusion from these figures alone, however, 
given the differences in maternal demographics 
and definitions of stillbirth and intrapartum death 
that exist internationally (2).
It has also been recognised that in countries 
where women receive good quality intrapartum 
care, the proportion of intrapartum deaths is 
less than 10% of all stillbirths (5). Since 2011 there 
have been 1,513 stillbirths in the ROI (3.6 per 
1000 live births, uncorrected for major congenital 
malformations) and intrapartum deaths make 
up 7.8% of all cases. While these figures point 
towards good overall intrapartum care they are 
only numbers, and perhaps do not tell the full 
story. 
Despite the limitations of the data, I believe there 
are lessons in this analysis for care. I offer four 
such suggestions relating to particular areas of 
maternity care. These suggestions are based 
upon my analysis of the NPEC data and are 
reflective of areas where appropriate clinical 
What do these findings represent and how can 
we reduce our intrapartum death rate further? 
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improvement as well as financial investment may 
help to further reduce our intrapartum death rate. 
These suggestions will not be new or surprising, 
and for the most part echo points made in 
previous NPEC perinatal reports as well as the 
invited commentaries on stillbirth by Dr Keelin 
O’Donoghue and Professor Richard Greene (7, 15).
1.  Improvement in Public Health 
Education
Maternal smoking, maternal obesity and late 
booking to a healthcare provider in pregnancy 
have previously been associated with all types 
of stillbirth, including intrapartum fetal death 
and adverse pregnancy outcome (2, 16-18). 
Analysis of the NPEC data revealed that 28% 
of mothers smoked, while 34% were either 
over-weight or obese. Almost one-third of the 
mothers who experienced an intrapartum fetal 
death booked late or not at all in their pregnancy. 
Despite ongoing efforts by maternity healthcare 
providers to improve antenatal education, unless 
there is significant engagement from the public, 
as well as acceptance of the risks associated 
with these lifestyle choices, these efforts will 
be futile. A recent study by Nuzum et al, which 
surveyed 999 respondents from the general 
Irish population, identified that over half of 
respondents failed to identify any risk factors for 
stillbirth (19). With this in mind I suggest the need 
for a greater public health awareness programme 
with respect to the benefits of healthy eating, 
exercise, obesity modification and smoking 
cessation prior to pregnancy. This awareness 
programme could also educate future parents on 
the complications of pregnancy such as stillbirth. 
This information is best imparted some-time 
pre-conceptually to enable potential parents 
to optimise their lifestyle pre pregnancy. I note 
with considerable enthusiasm the development 
of Physical Education as a school leaving cert 
subject and this may offer an opportunity for 
enhanced education with respect to some of 
these important modifiable lifestyle areas.
2.  Improvement in Antenatal 
Recognition of Fetal Growth 
Restriction
Analysis of the NPEC dataset revealed that fetal 
growth restriction was present in over a quarter 
of the infants who died in labour and that this 
was antenatally suspected in just one case. Fetal 
growth restriction in utero is associated with 
perinatal death and consideration should be 
given to the use of customised growth centiles 
in order to aid accurate prediction of infants 
who do not meet their genetic growth potential 
(20-23). Identification of risk factors for fetal 
growth restriction is key and the subsequent 
management once it is identified may further 
reduce the risk of intrapartum fetal death (22, 
24, 25). Reasons why growth restriction was 
missed so frequently is not something that 
is collected by the NPEC in individual cases 
but it is a finding that is not unique to Ireland. 
Enhancing education programmes for maternity 
healthcare providers to ensure a standardised 
approach to both risk factor identification as 
well as antenatal surveillance of fetal growth 
should be of vital importance for healthcare 
policy makers. In addition to this the onus is on 
all maternity healthcare professionals to equip 
themselves with the most up to date knowledge 
about the risk factors for fetal growth restriction 
to facilitate identification and appropriate 
interventions.
3.  Perinatal Post-mortem 
Examination and Placental 
Histology
All international guidance (including Irish 
guidance) advocates for the routine use of post-
mortem examination and placental histology 
when investigating all types of stillbirth (11, 13, 
26). While placental histology was available in 
the majority of the cases I analysed (97.9%), 
according to the NPEC data less than one third 
of all intrapartum deaths were investigated 
with a post-mortem examination. Over half of 
parents were offered a post-mortem examination 
but declined. Of the normally formed infants in 
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this cohort, 61.2% did not have a post-mortem 
examination conducted. We cannot hope to 
reduce the Intrapartum Death Rate unless we 
have a thorough understanding of each individual 
intrapartum death and post-mortem examination 
is the gold standard investigation when searching 
for causality. It is unclear why so few infants 
had a perinatal post-mortem examination. One 
potential reason, in some hospitals, may have 
been lack of access to a dedicated perinatal 
pathologist. I echo the call made by the NPEC 
and Professor Greene in his invited commentary 
(7) for the development of a national perinatal 
pathology service. Such a service would provide 
equitable access for parents and healthcare 
providers to specialised perinatal pathologists 
irrespective of where the infant was born. It is to 
be hoped that this will be one of the priorities 
for the National Women and Infant’s Health 
Programme to resource in 2018.
This does not explain, however, why some 
parents who were offered a post-mortem 
declined nor is that information available in 
the NPEC dataset. From the existing literature 
on parental decision making with respect to 
perinatal post-mortem, it is clear that the timing 
of the discussion in relation to post-mortem 
can impact on whether a parent consents or 
declines the examination. In general if parents 
are given more time to process the information 
in relation to post-mortem then they are more 
likely to consent (27). Another one of the 
perhaps modifiable reasons is in relation to 
the way parents are counselled towards post-
mortem examination by health care professionals 
(28) . It has been shown that when parents 
are counselled by appropriately trained senior 
healthcare professionals that consent is more 
likely to be obtained (29). In Ireland, few, if 
any of our senior medical or midwifery staff 
are appropriately trained in all aspects of 
bereavement care including how to consent 
for perinatal post-mortem examination (4). 
With the publication and now implementation 
of the National Standards for Bereavement 
Care following Pregnancy Loss and Perinatal 
Death(30); this area is finally being given due 
attention. 
4.  Development of a confidential 
enquiry into Intrapartum fetal 
death. 
Analysis of the NPEC dataset revealed a 
number of interesting issues. I was able to 
identify risk factors for intrapartum death such 
as the relatively poor antenatal detection of 
fetal growth restriction, as well as high rates of 
maternal obesity and smoking. In addition it gave 
a very good insight into the reported causes of 
intrapartum death in the Republic of Ireland. I 
did not, however, have access to the mothers’ 
or infants’ maternity charts, and in particular the 
labour component. This meant that while I was 
able to document, for example, that eight infants 
died in labour secondary to intrapartum asphyxia 
it was not possible to conduct any analysis of 
these cases. It was, therefore, impossible to 
identify any good components or substandard 
aspects of maternity care or to postulate whether 
alterations in antenatal or intrapartum care would 
have made a difference to the outcomes. 
For the last number of years, both in their 
annual reports and invited commentaries, the 
NPEC have been vocal in recommending that 
a Confidential Enquiry into Perinatal Death in 
Ireland be established. Confidential enquiries are 
a proven, validated, external case review process 
that have been used extensively in the United 
Kingdom (26) to investigate maternal death and 
more recently perinatal, fetal and infant death 
(14). They are an anonymised, non-judgemental 
and transparent review process that focus on 
both good aspects of care as well as identifying 
areas for improvement. Since 2009, maternity 
units in the Republic of Ireland through NPEC 
have been contributing to these maternal death 
enquiries but as of yet have not contributed 
to the perinatal death investigations (31). 
Development of a confidential enquiry system 
into all perinatal deaths, including intrapartum 
fetal deaths would provide learning at both 
local and national levels. While healthcare 
professionals have an obligation to provide high-
quality evidence based care at all times (32), a 
confidential enquiry system will identify all areas 
in the patient journey that need to be improved, 
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including medical and lifestyle factors. There is 
undoubtedly currently a poor public perception 
of the Irish maternity services and a confidential 
enquiry system will further enable us to be 
clear and open with parents with respect to the 
review process and this might improve the public 
perception of how these cases are dealt with. 
I suggest a confidential enquiry process into 
perinatal death alone misses an opportunity for 
learning, and any such process should also review 
the care received by infants who are born with 
a severe brain injury. Reviewing the intrapartum 
care provided to these infants has the potential 
to provide us with unique insights that may not 
be identifiable from analysis of perinatal deaths 
alone. The Each Baby Counts programme, 
supported by the Royal College of Obstetricians 
and Gynaecologists in the UK collects and pools 
the results of local risk management reviews on 
the care received by infants who have died in 
labour, shortly after labour or who have suffered 
a severe brain injury at birth (33). In addition 
they have started assessing the quality of these 
local risk management reviews and to date have 
identified that almost one third (27%) did not 
contain enough clinical information to allow care 
to be appraised (9). With this in mind one further 
suggestion is that an Irish Confidential Enquiry 
System into Perinatal Deaths be extended to 
include those infants who suffer a severe brain 
injury. The optimal model would, therefore, be a 
national tool to facilitate a high quality enquiry 
in to all these cases. This tool could then be used 
at both local level, and be reviewed at hospital 
groups, and reviewed at a national level as 
necessary. 
Conclusion
As maternity healthcare professionals we do a lot of good work on a day to day basis; 
much of it happens quietly and remains largely unseen. Sometimes, even with best care, 
serious adverse events such as intrapartum deaths do happen and not all are preventable. 
All need to be investigated, however. The data available from NPEC is good but there is an 
absolute need for Confidential Enquiries. There is still a lot to learn and a lot to be improved 
upon and in order to facilitate this we urgently need enhanced recognition, support and 
investment from healthcare policy makers. Investment to assist the learning suggested by 
this analysis could reap great dividends for the health service in fewer deaths and brain 
injuries around the time of birth. This would be a significant benefit for the parents and 
families who use our maternity services every day.
Acknowledgements
I wish to acknowledge Dr Paul Corcoran for providing some of the statistics 
used in the analysis as well as my PhD supervisors Dr Keelin O’Donoghue and 
Professor Richard Greene for their contributions to this commentary.
Dr Karen McNamara
Specialist Registrar and Clinical Research Fellow in Obstetrics and Gynaecology
53ANNUAL REPORT 2016
1.  Lawn JE, Kinney M, Lee AC, Chopra M, Donnay F, Paul VK, et 
al. Reducing intrapartum-related deaths and disability: can the 
health system deliver? International journal of gynaecology and 
obstetrics: the official organ of the International Federation of 
Gynaecology and Obstetrics. 2009;107 Suppl 1:S123-40, s40-2.
2.  Lawn JE, Blencowe H, Waiswa P, Amouzou A, Mathers C, Hogan 
D, et al. Stillbirths: rates, risk factors, and acceleration towards 
2030. The Lancet.387(10018):587-603.
3.  Breeze ACG, Lees CC. Intrapartum deaths: missed opportunities. 
Obstet Gynaecol Reprod Med. 2009;19(6):164-8.
4.  McNamara K, Meaney S, O’Connell O, McCarthy M, Greene 
RA, O’Donoghue K. Healthcare professionals’ response to 
intrapartum death: a cross-sectional study. Arch Gynecol 
Obstet. 2017.
5.  Darmstadt GL, Yakoob MY, Haws RA, Menezes EV, Soomro T, 
Bhutta ZA. Reducing stillbirths: interventions during labour. 
BMC pregnancy and childbirth. 2009;9 Suppl 1:S6.
6.  Goldenberg RL, McClure EM, Bann CM. The relationship of 
intrapartum and antepartum stillbirth rates to measures of 
obstetric care in developed and developing countries. Acta 
obstetricia et gynecologica Scandinavica. 2007;86(11):1303-9.
7.  Corcoran P, Manning E , O’Farrell IB, McKernan J, Meaney 
S, Drummond L, et al. Perinatal Mortality in Ireland Annual 
Report,National Perinatal Epidemiology Centre. Cork: National 
Perinatal Epidemiology Centre; 2016.
8.  Kiely JL, Paneth N, Susser M. Fetal death during labor: an 
epidemiologic indicator of level of obstetric care. American 
journal of obstetrics and gynecology. 1985;153(7):721-7.
9.  Royal College of Obstetricians and Gynaecologists. Each Baby 
Counts: Key messages from 2015: London. RCOG. 2016.
10.  McNamara K, O’Donoghue K, Greene RA. Intrapartum fetal 
deaths and unexpected neonatal deaths in the Republic of 
Ireland: 2011 – 2014; a descriptive study. BMC pregnancy and 
childbirth. 2018;18(1):9.
11.  Institute of Obstetricians and Gynaecologists, Royal College 
of Physicians of Ireland, and Directorate of Strategy and 
Clinical Programmes, Health Service Executive Investigation 
and Management of late fetal intrauterine death and stillbirth, 
Version 1.0, October 2011.
12.  Royal College of Obstetricians and Gynaecologists. Greentop 
Guideline No. 55. Late Intrauterine Death and Stillbirth. October 
2010.
13.  ACOG Practice Bulletin No. 102: management of stillbirth. 
Obstet Gynecol. 2009;113(3):748-61.
14.  Manktelow BN, Smith LK, Seaton SE, Hyman-Taylor P, Kurinczuk 
JJ, Field DJ, et al. MBRRACE-UK Perinatal Mortality Surveillance 
Report, UK Perinatal Deaths for Births from January to 
December 2014: The Infant Mortality and Morbidity Studies, 
Department of Health Sciences, Univeristy of Leicester. 2016.
15.  Manning E, Corcoran P, Meaney S , Greene RA, on behalf of the 
Perinatal Mortality Group. Perinatal Mortality in Ireland Annual 
Report 2013. Cork: National Perinatal Epidemiology Centre, 
2015.
16.  Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan 
WM, et al. Maternal obesity and risk of stillbirth: a 
metaanalysis. American journal of obstetrics and gynecology. 
2007;197(3):223-8.
17.  Heslehurst N, Lang R, Rankin J, Wilkinson JR, Summerbell CD. 
Obesity in pregnancy: a study of the impact of maternal obesity 
on NHS maternity services. BJOG : an international journal of 
obstetrics and gynaecology. 2007;114(3):334-42.
18.  Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, 
et al. Maternal obesity and pregnancy outcome: a study of 
287,213 pregnancies in London. International journal of obesity 
and related metabolic disorders : journal of the International 
Association for the Study of Obesity. 2001;25(8):1175-82.
19.  Nuzum D, Meaney S, O’Donoghue K. The public awareness 
of stillbirth: an Irish population study. BJOG : an international 
journal of obstetrics and gynaecology. 2018;125(2):246-52.
20.  Stacey T, Thompson JM, Mitchell EA, Zuccollo JM, Ekeroma AJ, 
McCowan LM. Antenatal care, identification of suboptimal fetal 
growth and risk of late stillbirth: findings from the Auckland 
Stillbirth Study. The Australian & New Zealand journal of 
obstetrics & gynaecology. 2012;52(3):242-7.
21.  Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly 
MM, Dornan J, et al. The customized fetal growth potential: a 
standard for Ireland. European journal of obstetrics, gynecology, 
and reproductive biology. 2013;166(1):14-7.
22.  Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. 
Maternal and fetal risk factors for stillbirth: population based 
study. BMJ (Clinical research ed). 2013;346:f108.
23.  McCowan LM, George-Haddad M, Stacey T, Thompson JM. 
Fetal growth restriction and other risk factors for stillbirth in a 
New Zealand setting. The Australian & New Zealand journal of 
obstetrics & gynaecology. 2007;47(6):450-6.
24.  de Bernis L, Kinney MV, Stones W, Ten Hoope-Bender P, Vivio D, 
Leisher SH, et al. Stillbirths: ending preventable deaths by 2030. 
Lancet (London, England). 2016;387(10019):703-16.
25.  Saastad E, Vangen S, Froen JF. Suboptimal care in stillbirths - 
a retrospective audit study. Acta obstetricia et gynecologica 
Scandinavica. 2007;86(4):444-50.
26.  Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, 
Brocklehurst P, et al. Saving Lives, Improving Mothers’ Care - 
Surveillance of maternal deaths in the UK 2012-14 and lessons 
learned to inform maternity care from the UK and Ireland 
Confidential Enquiries into Maternal Deaths and Morbidity 
2009-14. Oxford: National Perinatal Epidemiology Unit, 
University of Oxford 2016.; 2106.
27.  Meaney S, Gallagher S, Lutomski JE, O’Donoghue K. Parental 
decision making around perinatal autopsy: a qualitative 
investigation. Health expectations : an international journal 
of public participation in health care and health policy. 
2015;18(6):3160-71.
28.  Downe S, Kingdon C, Kennedy R, Norwell H, McLaughlin MJ, 
Heazell AE. Post-mortem examination after stillbirth: views 
of UK-based practitioners. European journal of obstetrics, 
gynecology, and reproductive biology. 2012;162(1):33-7.
29.  Stock SJ, Goldsmith L, Evans MJ, Laing IA. Interventions to 
improve rates of post-mortem examination after stillbirth. 
European journal of obstetrics, gynecology, and reproductive 
biology. 2010;153(2):148-50.
30.  Health Service Executive. National Standards for Bereavement 
Care Following Pregnancy Loss and Perinatal Death. 2016.
31.  O’Hare MF, Manning E, O’Herlihy C, Greene RA, on behalf of 
MDE Ireland. Confidential Maternal Death Enquiry in Ireland, 
Report for 2009 - 2012. Cork: MDE Ireland, February 2015.
32.  Medical Council of Ireland. Guide to professional conduct and 
ethics for registered medical practitioners. 2009.
33.  Royal College of Obstetricians and Gynaecologists. Each Baby 
Counts: 2015 Summary Report. London: RCOG, 2017. 2017. 
References 
54 PERINATAL MORTALITY IN IRELAND 
3. Stillbirths: Specific findings
Cause of death in stillbirths
Major congenital anomaly was the primary 
cause of death in over thirty percent (n=78, 
31.2%) of the 250 stillbirths that occurred in 2016 
(Figure 3.1). There was a chromosomal disorder 
in over sixty percent of the 78 stillbirths due 
to congenital anomaly (n=50, 64.1%). In these 
cases, over sixty five percent were diagnosed 
by cytogenetic analysis (n=33 of 50, 66%). 
Anomalies of the central nervous system 
(n=5), the urinary tract (n=3) as well as the 
cardiovascular (n=3), musculo-skeletal (n=3) 
and gastro-intestinal (n=3) systems collectively 
caused 17 additional (27.7%) stillbirths.
Table 3.1 shows further detail into the causes of 
death for stillbirths. Specific placental conditions 
were diagnosed in over one quarter (n=70, 
28.0%) of stillbirth cases. The most commonly 
occurring placental condition was maternal 
vascular malperfusion (n=24 of 70, 34.3%). 
In less than ten percent of stillbirths, specific 
mechanical causes were the main factor leading 
to death (n=20, 8.0%). The majority of these were 
due to the umbilical cord around the baby’s neck 
or another entanglement or knot in the umbilical 
cord. Antepartum or intrapartum haemorrhage 
(n=18, 7.2%) and specific fetal conditions (n=9, 
3.6%) were the next most common cause of 
death. 
In over three percent of stillbirths, infection was 
the main cause of death (n=9, 3.6%). This was a 
visible decrease from last year’s percentage of 
cases due to infection, recorded at 8.2% (24 of 
294 stillbirths in 2015). 
Figure 3.1: Primary cause of death in stillbirths (left chart) and detailed cause in cases of major congenital 
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Major congenital anomaly 80 (26.3%) 69 (22.9%) 83 (25.2%) 79 (26.9%) 78 (31.2%)
Central nervous system 11 10 9 3 5
Cardiovascular system 5 9 5 3 3
Respiratory system 1 1 - 1
Gastro-intestinal system 2 2 2 3
Urinary tract 2 6 4 2 3
Musculo-skeletal system 1 1 1 3 3
Multiple anomalies 10 5 3 3 6
Chromosomal disorders 38 33 57 52 50
Metabolic disorders - - - - -
Other major congenital anomaly 10 2 2 13 4
Specific placental conditions 1 73 (24.0%) 66 (21.9%) 82 (24.8%) 71 (24.1%) 70 (28.0%)
Maternal vascular malperfusion2 22 32 26 24
Fetal vascular malperfusion2 16 16 18 15
Cord pathology2 9 17 15 15
Cord Pathology with Distal Disease - - - - 9
Delayed villous maturation3 8 7 8 2
Chorioamnionitis - 1 1 -
Villitis 4 2 5 3 -
Other placental condition 20 8 4 1 5
Mechanical 25 (8.2%) 30 (10.0%) 28 (8.5%) 19 (6.5%) 20 (8%)
Prolapse cord 1 2 3 3 2
Cord around neck 14 18 17 11 10
Other cord entanglement or knot 10 9 7 5 7
Uterine rupture before labour - 1 1 - 1
Uterine rupture during labour - - - - -
Mal-presentation - - - - -
Shoulder dystocia - - - - -
Antepartum or intrapartum haemorrhage 21 (6.9%) 26 (8.6%) 32 (9.7%) 21 (7.1%) 18 (7.2%)
Praevia - - - 1 -
Abruption 21 26 31 20 18
Uncertain haemorrhage - - 1 - -
1The main placental pathology associated with perinatal death is reported.
2Reported abnormal placental histology was not classified under these categories for the years 2011 and 2012. 
3  The term ‘Delayed villous maturation’ (DVM) has replaced conditions previously reported as ‘Placental maturation defect’.  
DVM includes distal villous immaturity and delayed villous maturation.
For approximately fifteen percent of stillbirths 
(n=38, 15.2%), the cause of death was 
unexplained. This is similar to the proportion 
in 2015 (n=46, 15.6%) and 2014 (n = 49, 14.8%). 
For over forty percent of the stillbirths with 
unexplained cause of death, it was reported 
that there were no antecedents or associated 
obstetric factors (n=17, 44.7%). For the majority 
of the cases with unexplained death, an autopsy 
was performed (n=25 of 38, 65.8%). Autopsy 
was offered but not performed in 12 cases where 
death was unexplained (31.6%). There was only 
one additional unexplained stillbirth where an 
autopsy was not performed nor offered. In this 
case antecedents or associated obstetric factors 
impacting on the death were present (n=1, 2.6%). 
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Infection 16 (5.3%) 17 (5.6%) 22 (6.7%) 24 (8.2%) 9 (3.6%)
Maternal
 Bacterial - - 2 - 1
 Syphilis - - - - -
 Viral diseases 2 1 - - 1
 Protozoal - - - - -
 Group B Streptococcus 1 3 2 - 1
 Other maternal infection - 1 - 1 -
Ascending infection
 Chorioamnionitis 11 9 15 23 4
 Other ascending infection 2 3 3 - 2
Specific fetal conditions 9 (3.0%) 14 (4.7%) 21 (6.4%) 24 (8.2%) 9 (3.6%)
Twin-twin transfusion 4 6 9 11 1
Feto-maternal haemorrhage 2 4 6 7 3
Non immune hydrops - 1 2 4 3
Iso-immunisation - - 1 - -
Other fetal condition 3 3 3 2 2
Intra-uterine growth restriction 6 (2.0%) 5 (1.7%) 7 (2.1%) 8 (2.7%) 4 (1.6%)
IUGR - Suspected antenatally 4 2 5 7 4
IUGR - Observed at delivery 1 1 2 - -
IUGR - Observed at post mortem 1 2 - 1 -
Associated obstetric factors 3 (1.0%) 2 (0.7%) 1 (0.3%) - 2 (0.8%)
Intracranial haemorrhage - - - - -
Birth injury to scalp - - - - -
Fracture - - - - -
Other birth trauma - - - - -
Intrapartum asphyxia - - - - 2
Polyhydramnios - - - - -
Oligohydramnios - - - - -
Premature rupture of membranes - - - - -
Prolonged rupture of membranes - - 1 - -
Spontaneous premature labour 2 2 - - -
Other obstetric factors 1 - - - -
Maternal disorder 0 (0.0%) 1 (0.3%) 3 (0.9%) 2 (0.7%) 0 (0.0%)
Pre-existing hypertensive disease - - - - -
Diabetes - - - 1 -
Other endocrine conditions - - - - -
Thrombophilias - - 1 - -
Obstetric cholestasis - - - - -
Drug misuse - - - - -
Uterine anomalies - - 1 - -
Other maternal disorder - 1 1 1 -
Hypertensive disorders of pregnancy 2 (0.7%) 0 (0.0%) 2 (0.6%) - 2 (0.8%)
Pregnancy induced hypertension - - 2 - 1
Pre-eclampsia toxaemia 2 - - - 1
HELLP syndrome - - - - -
Eclampsia - - - - -
Unexplained 69 (22.7%) 71 (23.6%) 49 (14.8%) 46 (15.6%) 38 (15.2%)
No antecedents or associated obstetric factors 30 26 28 19 17
Antecedents or associated obstetric factors present 38 36 18 25 15
Very limited information available - 4 - - 1
Pending post mortem or other investigation 1 5 3 2 5
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Management of women experiencing 
antepartum stillbirths 
Factors influencing the delivery management 
of women experiencing antepartum stillbirths 
include maternal choice, maternal wellbeing, 
risk of developing severe medical complications 
and previous obstetric history. Management of 
clinical care may involve planned induction of 
labour, awaiting spontaneous labour or in some 
cases elective delivery by caesarean section.40
In 2016, 229 women experienced antepartum 
stillbirth (91.6% of all the stillbirths) (Table 3.3). 
The management of clinical care (i.e. whether 
the care involved planned induction of labour 
or awaiting spontaneous labour, elective 
delivery by caesarean section) was recorded 
for all the 229 women who experienced 
antepartum stillbirth. Labour was induced for 
over half of the 229 women who experienced 
antepartum stillbirth (n=143, 62.4%) whereas 
labour was spontaneous for 19.7% (n=45). 
As shown in Figure 3.2, the time from diagnosis 
of fetal demise to delivery was different for 
women whose labour was induced from the 
delivery time for women whose labour was 
spontaneous. The confirmation of death and 
delivery took place on the same day for 57.1% 
(n=25 of 45) of the women whose labour was 
spontaneous. For women whose labour was 
induced, it was common for up to three days 
to pass between diagnosis and delivery. As can 
be observed from Figure 3.2, a small number 
of antepartum stillbirths (n=6), were delivered 
more than two weeks after confirmation of fetal 
demise. Of these six cases, all but one case 

























Figure 3.2: Time from confirmation of fetal demise to delivery for women who experienced 
antepartum stillbirth in 2016 
40 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of Obstetricians and 
Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.
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Vaginal birth is the recommended mode 
of delivery for most women experiencing 
antepartum stillbirth, but caesarean section may 
be clinically indicated in some cases.41 Vaginal 
cephalic delivery was the most common mode 
of delivery in cases of antepartum stillbirth 
(n=141, 61.6%).
In 36 cases of antepartum stillbirth (15.7% of all 
antepartum stillbirths, unknown for four cases), 
the intended mode of delivery was a planned 
caesarean section and ultimately, caesarean 
section was the mode of delivery for 46 women 
(20.1%; 41 pre-labour caesarean sections and 
five caesarean sections performed after onset of 
labour). Of these 46 women, the indication for 
caesarean section was classified as ‘elective’ in 
52.2% of the cases, 10.9% were ‘urgent’ and 37% 
were ‘emergency’ (Table 3.2). Over fifty percent 
(n=24, 52.2%) of the 46 women who delivered 
by caesarean section had previously had a 
caesarean section and 24% (n=11, 23.9%) had a 
multiple delivery, both of these were factors that 
may have influenced the mode of delivery.
41  Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of Obstetricians and 
Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive. 
Table 3.2: Indication for caesarean section in women experiencing antenatal stillbirth in 2016
Indication for caesarean section n (%)
Elective: At a time to suit the woman or the maternity team 24 (52.2)
Urgent: Maternal or fetal compromise which is not 
immediately life threatening
5 (10.9)
Emergency: Immediate threat to life of woman or baby 17 (37)
Note: Values are n(%) unless otherwise stated.
The location of delivery for the vast majority of antepartum stillbirths was in obstetric-led 
maternity units (n=228, 99.6%) with one antepartum stillbirth (0.4%) being born before 
arrival (BBA), and therefore, unattended.
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42  Darmstadt G, Yakoob M, Haws R, Menezes E, Soomro T and Bhutta Z. Reducing stillbirths: interventions during labour. BMC Pregnancy and 
Childbirth 2009;9 (Suppl 1):s6
43 Manktelow BN, Smith LK, Prunet C, Smith PW, Boby T, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Draper ES, on behalf of the MBRRACE-UK 
Collaboration. MBRRACE-UK Perinatal Mortality Surveillance Report, UK Perinatal Deaths for Births from January to December 2015. Leicester: 
The Infant Mortality and Morbidity Studies, Department of Health Sciences, University of Leicester. 2017 
Intrapartum stillbirths 
It has been suggested that the comparatively 
low proportion of intrapartum stillbirths in high-
income countries indicates that fetal deaths 
occurring in labour, in non-anomalous babies, are 
most likely preventable with quality intrapartum 
care.42 Intrapartum deaths in this audit were 
identified by a specific question on the NPEC 
Perinatal Death Notification Form (Appendix E) 
as to whether the baby was alive at the onset 
of care in labour. This was not known in three 
cases (Table 3.3) which involved two unattended 
births (the baby being born before arrival at 
maternity unit) and one baby delivered at general 
adult hospital. There were 18 cases of stillbirths 
where the baby was known to be alive at the 
onset of care in labour. Thus, intrapartum deaths 
accounted for 7.2% of stillbirths in Ireland in 2016 
(Table 3.3). This was higher than the proportion 
of intrapartum deaths reported in 2015 in Ireland 
(n=18, 6.1% of stillbirths) but generally lower 
than the most recently published figures in UK 
countries, ranging from 13% in Scotland to 11.7% 
in Wales, 9.2% in England and 6.3% in Northern 
Ireland.43
Table 3.3: Life status of baby at the onset of care in labour for stillbirths in 2016
Type of Stillbirth case Description n (%)
Antepartum
Baby not alive at onset of care in 
labour (Antepartum Stillbirth)
188 (75.2)
Never in labour 41 (16.4)
Intrapartum Baby alive at onset of care in labour 18 (7.2)
Not known 3 (1.2)*
*Two of these cases were unattended births (BBA at maternity unit) and one case was delivered at a general adult hospital.
Major congenital anomaly was the primary cause of death for 50% of the 18 intrapartum 
deaths (n= 9). Specific placental conditions was the second most common cause of death, 
although accounting only for three (16.7%) of the 18 intrapartum deaths. Other cases involved 
infection (n=2), associated obstetric factors (n=1) or intrapartum haemorrhage (n=1) and in 
two cases the primary cause of death remains unexplained.  
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4. Early neonatal deaths: Specific findings
Cause of early neonatal death
The cause of early neonatal deaths was classified 
using both the NPEC Neonatal Classification 
System and the NPEC Maternal and Fetal 
Classification System in order to identify both 
the primary neonatal condition causing the death 
and the underlying main antecedent or obstetric 
factor associated with the death.
Major congenital anomaly was the primary cause 
of death for almost fifty five percent (n=68, 
54.8%) of the 124 early neonatal deaths (Figure 
4.1) followed by respiratory disorder, accounting 
for more than one in four (n=36, 29%) of early 
neonatal deaths. Neurological disorder was the 
next most common cause of death, causing over 
six percent of early neonatal deaths (n=8, 6.5%). 
Five deaths (4.0%) were unexplained pending 
post mortem or other investigation. A detailed 
listing of the main cause of death for the 124 
early neonatal deaths is given at the end of this 
section of the report (Table 4.3).
Major congenital anomalies 
The types of major congenital anomalies 
which caused 68 of the 124 neonatal deaths 
are illustrated in Figure 4.1 (upper chart). 
Chromosomal disorders were the most common 
type of major congenital anomaly, occurring in 
over one in four cases (n=18, 26.5%). The second 
most frequent anomalies were those of the urinary 
tract occurring in over fifteen percent of the 
cases within the major congenital anomaly group 
(n=11, 16.2%). Other occurring anomalies included 
disorders of the cardiovascular system (n=9, 13.2%) 
and of the central nervous system (n=7, 10.3%). 
The vast majority of the 18 neonatal deaths 
attributed to a chromosomal disorder were 
diagnosed by cytogenetic analysis (n=14, 77.7%).
Respiratory disorders 
Of the 36 early neonatal deaths caused by 
respiratory disorder, nearly seventy percent 
(n=25, 69.4%) were due to severe pulmonary 
immaturity (Figure 4.1, lower right chart). 
Pulmonary hypoplasia occurred in one in seven 
cases (n=5, 13.9%). All but five of the 36 early 
neonatal deaths attributed to respiratory disorder 
occurred in babies delivered before 28 weeks 
gestation (Table 4.1). This pattern of gestational 
age was in marked contrast to the early neonatal 
deaths due to major congenital anomaly and to 
those due to all other causes (Table 4.1).
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Figure 4.1: Primary cause of early neonatal death (upper chart), cases of major congenital anomaly 



























Central nervous system (10.3%)
Musculo-skeletal system (8.8%)
Respiratory system (4.4%)






Severe pulmonary immaturity (69.4%)
Pulmonary hypoplasia (13.9%)
Other respiratory disorder (5.6%)
Surfactant deficiency lung disease (11.1%)
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Table 4.1: Gestational age distribution in neonatal deaths by broad main cause of death in 2016










≥ 42  
weeks
Respiratory disorder 0 (0%) 31 (86.1%) 4 (11.1%) 1 (2.8%) 0 (0%) 0 (0%)
Major congenital anomaly 0 (0%) 8 (11.8%) 5 (7.4%) 28 (41.2%) 26 (38.2%) 1 (1.5%)
All Other 0 (0%) 8 (42.1%) 3 (15.8%) 3 (15.8%) 6 (31.6%) 0 (0%)
Note: Values are n (%) unless otherwise stated. 
Neurological disorders 
A neurological disorder was attributed as the 
main cause of eight early neonatal deaths. 
For five of these cases, the condition involved 
was hypoxic ischaemic encephalopathy 
(HIE) and for three cases death was due to 
intraventricular/periventricular haemorrhage. 
Table 4.2 details the gestational age, customised 
birthweight centile and main antecedent or 
obstetric factor associated with the eight early 
neonatal deaths attributed to neurological 
disorders. Five of these eight cases occurred in 
babies with a gestational age of 37-41 weeks. 
Six of these eight early neonatal deaths had an 
autopsy performed and four became coroner 
cases. 







Main antecedent or obstetric factor 




secondary to vasa praevia
Autopsy not performed 
and not offered
HIE 39 99th Placental Abruption
Autopsy performed 
(Coroner Case)
HIE 40 11th Fetal Maternal Haemorrhage
Autopsy performed 
(Coroner Case)
HIE 38 26th Tear in chorionic vein
Autopsy performed 
(Coroner Case)
HIE 41 46th Meconium Aspiration
Autopsy performed 
(Coroner Case)
IVH/PVH 26 1st Placental Abruption Autopsy performed
IVH/PVH 24 88th Spontaneous premature labour Autopsy performed
IVH/PVH 23 48th Spontaneous premature labour
Autopsy not performed 
and not offered
Note: IVH/PVH = Intraventricular/periventricular haemorrhage; HIE = hypoxic ischaemic encephalopathy. 
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Major congenital anomaly 68 (48.2%) 92 (56.8%) 68 (48.2%) 98 (59%) 68 (54.8%)
Central nervous system 7 19 7 11 7
Cardiovascular system 7 9 7 16 9
Respiratory system 2 1 2 1 3
Gastro-intestinal system 2 2 1 4 -
Musculo-skeletal system 2 1 3 5 6
Multiple anomalies 12 17 8 11 8
Chromosomal disorders 17 25 26 17 18
Metabolic disorders  
(in-born errors of metabolism)
2 - - 1 3
Urinary tract 13 9 10 19 11
Other major congenital anomaly 4 9 4 13 3
Pre-viable (<22 weeks) 1 (0.7%) 1 (0.6%) 1 (0.7%) 1 (0.6%) 0 (0%)
Respiratory disorders 44 (31.2%) 53 (32.7%) 46 (32.6%) 41 (24.7%) 36 (29%)
Severe pulmonary immaturity 29 32 35 31 25
Surfactant deficiency lung disease 9 14 5 1 4
Pulmonary hypoplasia 1 2 4 4 5
Meconium aspiration syndrome - - - - -
Primary persistent pulmonary hypertension 1 - - 1 -
Chronic lung disease/bronchopulmonary 
dysplasia
- - - - -
Other respiratory disorder 4 5 2 4 2
Gastro-intestinal disease 3 (2.1%) 1 (0.6%) 2 (1.4%) - 1 (0.8%)
Necrotising enterocolitis 2 1 2 - 1
Other gastro-intestinal disease 1 - - - -
Neurological disorder 14 (9.9%) 10 (6.2%) 9 (6.4%) 17 (10.2%) 8 (6.5%)
Hypoxic-ischaemic encephalopathy 10 9 7 13 5
Intraventricular/periventricular haemorrhage 2 1 2 4 3
Other neurological disorder 2 - - - -
Infection 4 (2.8%) 3 (1.9%) 12 (8.5%) 3 (1.8%) 4 (3.2%)
Sepsis 2 1 7 - 4
Pneumonia 1 1 2 1 -
Meningitis - - 1 - -
Other infection 1 1 2 2 -
Injury/Trauma - - - - -
Other specific causes 3 (2.1%) 1 (0.6%) - 2 (1.2%) 2 (1.6%)
Malignancies/tumours - - - - -
Other specific cause 3 1 - 2 2
Sudden unexpected deaths 2 (1.4%) - 1 (0.7%) 1 (0.6%) -
Sudden infant death syndrome (SIDS) 2 - 1 1 -
Infant Deaths - Cause Unascertained - - - - -
Unexplained 2 (1.4%) 1 (0.6%) 2 (1.4%) 3 (1.8%) 5 (4%)
No antecedents or associated obstetric 
factors
1 - - - -
Antecedents or associated obstetric factors 
present
- - - - -
Very limited information available - - - - -
Pending post mortem or other investigation 1 1 2 3 5
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Condition and management at birth 
The NPEC Perinatal Death Notification Form 
(Appendix E) records the condition, in terms of 
respiratory activity and heart rate shortly after 
delivery, of babies who die in the early neonatal 
period. For most of these babies (n=71 of 124, 
57.3%, unknown for two cases), spontaneous 
respiratory activity was absent or ineffective 
at five minutes following delivery and for 42% 
(n=52, unknown for two cases) the heart rate 
was persistently less than 100 beats per minute.
In most cases of early neonatal death, active 
resuscitation was offered in the delivery room 
(n=70 of 124 ENNDs). Of the early neonatal 
deaths not receiving resuscitation (n=54), 
the majority (n=36) were associated with a 
major congenital anomaly (Table 4.4). Those 
born without major congenital anomaly and 
not offered resuscitation were delivered 
prematurely between 22-27 weeks gestation. 
Table 4.4: Deaths due to major congenital anomaly among early neonatal deaths not offered resuscitation 
(n=54): 2016
Gestation at delivery 22-27 weeks 28-31 weeks 32-36 weeks 37-41 weeks ≥ 42 weeks Total
Total ENNDs not offered 
resuscitation 19 4 13 17 1 54
Death due to Major 
congenital anomaly 2 (5.56%) 4 (11.11%) 12 (33.33%) 17 (47.22%) 1 (2.78%) 36
Note: Values are n(%) unless otherwise stated.
Fifty percent of early neonatal babies were 
admitted to a neonatal unit in the hospital of 
delivery (n=62, 50% of 124) and almost ten 
percent of babies (n=12, 9.7%) were transferred 
to another unit. Such admission and transfer 
depended on whether active resuscitation had 
been offered in the delivery room. Admission 
to a neonatal unit followed over eighty percent 
of the cases offered active resuscitation (n=58, 
82.9%) compared to seven percent not offered 
active resuscitation (n=4 in 54 cases not offered 
resuscitation, 6.4%) (Table 4.5). Fifteen percent 
of cases offered active resuscitation were 
transferred to another unit (n=11, 15.7% of 70 
cases offered resuscitation) compared to just 
one percent of babies not offered resuscitation 
(n=1, 0.8%).
Table 4.5: Management at birth of babies who died within the first week of birth, 2016
Baby admitted to neonatal unit Baby transferred to another unit
Resuscitation
Yes (n =70) 58 (82.9%) 11 (15.7%)
No (n = 54) 4 (6.4%) 1 (0.8%)
Note: Values are n (%) unless otherwise stated. *One case missing information regarding transfer to another unit
Age of neonate at death 
Over two thirds of the early neonatal deaths occurred within 24 hours of delivery (Table 4.6). 
Major congenital anomaly and severe pulmonary immaturity were the main cause of death in 
55.8% (n=48) and 32.6% (n=28) of these cases, respectively.
Table 4.6: Age of neonate at death, 2016
Completed days 0 1 2 3 4 5 6
Number 86 15 5 8 3 4 2
% 69.9 12.2 4.1 6.5 2.4 3.3 1.6
Cumulative % 69.9 82.1 86.2 92.7 95.1 98.4 100
Age of neonate at death unknown for one case 
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Location of neonatal death 
The vast majority of early neonatal deaths occurred either in the neonatal unit, the labour ward, or in 
another maternity unit ward (Table 4.7). A very small proportion of deaths occurred in a paediatric centre. 
All 46 neonatal deaths that occurred in the labour ward occurred within 24 hours of delivery. 
These 46 deaths in the labour ward accounted for over half of the neonatal deaths that 
occurred in the first day after birth (total n=86). A further 27.9% (n=24) of first day neonatal 
deaths occurred in a neonatal unit. As detailed in Table 4.6, the daily number of neonatal 
deaths was significantly lower once 24 hours had elapsed after delivery. Over three quarters 
of the neonatal deaths after 1-6 completed days (n=37) happened in a neonatal unit (n=29, 
78.4%) and a further 16.2% of these deaths (n=6) occurred in a ward (Figure 4.2). 
Table 4.7: Location of neonatal death, 2016
Place of death  n (%)
Labour ward 46 (37.1)
Neonatal unit 53 (42.7)
Ward of the maternity unit 13 (10.5)
Paediatric centre 4 (3.2)
At home 3 (2.4)
Theatre 5 (4)
Note: Values are n(%) unless otherwise stated.
Figure 4.2: Place of neonatal death 0-6 complete days after birth, 2016 
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5.  Perinatal deaths associated 
with intrapartum events 
The investigation of perinatal deaths due to 
intrapartum events is valuable in assessing 
quality of care. These deaths are unexpected 
and include stillbirths alive at the onset of 
professional care in labour and neonatal deaths. 
Traditionally intrapartum deaths referred to 
babies who were alive at onset of labour but 
stillborn. The inclusion of neonatal deaths 
facilitates the assessment of all perinatal deaths 
that may have an intrapartum origin.
We reviewed perinatal deaths reported in 2016, 
focusing on cases with a gestational age of at 
least 34 weeks and a birthweight of at least 
2,500g who were alive at the onset of care in 
labour and whose death was not due to major 
congenital anomaly or infection. Babies who 
were delivered by pre-labour caesarean section 
were not included. 
In 2016, there were 29 cases of perinatal death 
with a gestational age of at least 34 weeks and a 
birthweight of at least 2,500g who were alive at 
the onset of care in labour. There were no cases 
with death due to infection and 18 of the 29 
perinatal deaths mentioned above were due to 
major congenital anomaly (n=18, 62.0%). 
Therefore, in total in 2016, there were 11 perinatal 
deaths (four stillbirths and seven early neonatal 
deaths) associated with intrapartum events 
with a gestational age of at least 34 weeks and 
a birthweight of at least 2,500g who were alive 
at the onset of labour and whose death was not 
due to major congenital anomaly or infection. 
Ten of the 11 deaths were coroner cases. Details 
of the cases are provided in Table 5.1 below.









Main antecedent or obstetric factor 
associated with the death
Neonatal cause of death Autopsy Uptake  
Yes/No
SB 37-41 9th Intrapartum asphyxia Not Applicable Yes (coroner case)
SB 37-41 15th Placental Abruption Not Applicable Yes (coroner case)
SB 37-41 68th
Meconium induced myonecrosis 
on a background of severe DVM*
Not Applicable Yes (coroner case)
SB 37-41 38th Pending post-mortem Not Applicable Yes (coroner case)
ENND 37-41 40th
Antepartum haemorrhage 
secondary to Vasa Previa
HIE
No Autopsy not 
performed and not 
offered
ENND 37-41 99th Placental Abruption HIE Yes (coroner case)
ENND 37-41 11th Fetal Maternal Haemorrhage HIE Yes (coroner case)
ENND 37-41 26th Tear in chorionic vein HIE Yes (coroner case)
ENND 32-36 92th Non-immune hydrops Right pleural effusion Yes (coroner case)
ENND 37-41 3th Pending post-mortem Pending post-mortem Yes (coroner case)
ENND 37-41 46th Meconium Aspiration HIE Yes (coroner case)
Note: *DVM = Delayed Villous Maturation; SB = Stillbirth; ENND = Early Neonatal Death; HIE = Hypoxic Ischaemic Encephalopathy.
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6. Late neonatal deaths: Specific findings
Data relating to 33 late neonatal deaths 
occurring in 2016 were reported to the NPEC for 
the purposes of this clinical audit. At the time 
of reporting, finalised figures for late neonatal 
deaths in 2016 were not yet published by the 
Central Statistics Office (CSO). However, in their 
provisional data, it was reported that 33 late 
neonatal deaths had occurred in 2016. 
In each of the preceding three years there has 
been some variation between the number of 
late neonatal deaths reported by the CSO and 
the number reported to the NPEC. For 2014, 
2015 and 2016 respectively, the CSO reported 
38, 32 and 33 late neonatal deaths while 33, 28 
and 33 were reported to the NPEC. Maternity 
hospitals may not be notified of the late 
neonatal death of a baby delivered in their unit 
if the baby was transferred to a paediatric unit 
or discharged home. The NPEC is working with 
colleagues in the relevant hospitals (maternity 
and paediatric) to address this issue.
Given the notification issue and the limited 
number of late neonatal deaths reported, this 
section of the report provides a brief summary 
of the submitted data as well as the detailed 
listing of the main cause of the 33 deaths 
according to the NPEC Classification System.
Table 6.1 describes a range of characteristics of 
the babies who died in the late neonatal period. 
Most of the babies who died in the late neonatal 
period were male. This is in line with previous 
years trends, although the values fluctuate from 
year to year. 
One third of the babies who died in the late 
neonatal period in 2016 were born by vaginal 
cephalic delivery (33.3%) and under thirty 
percent were delivered by pre-labour caesarean 
section (27.3%). Most had a gestational age 
between 22-27 weeks or 37-41 weeks at birth 
(n=12, 36.4% for each of these gestational 
groups) but over seventy percent (n=24, 72.7%) 
had a birthweight less than 2,500 grams. 
Over thirty percent of babies were small for 
gestational age (SGA; <10th centile).
In 2016, the proportion of late neonatal deaths 
was found to decrease across the second, 
third and fourth weeks of life. For example, the 
proportion of late neonatal deaths decreased 
from 51.5% in week two to 36.4% in week three 
to 12.2% in week four (Table 6.1).
Over half of late neonatal deaths in 2016 
occurred in the neonatal unit and almost one 
quarter died in a paediatric centre.
As shown in Table 6.2, almost half of late 
neonatal deaths were due to major congenital 
anomaly (n=15, 45.4%). The next most common 
causes were respiratory disorders (n=10, 30.3%) 
and neurological disorders (n=4, 12.1%). Other 
causes of death for these babies included 
gastrointestinal disorders (n=3, 9.1%), and 
sudden infant death syndrome (n=1, 3%).
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Table 6.1: Characteristics of late neonatal deaths in 2012-2016
2012 n (%) 
N=40
2013 n (%) 
N=37
2014 n (%) 
N=33
2015 n (%) 
N=28**
2016 n (%) 
N=33
Infant sex
Male 18 (45.0) 22 (59.5) 22 (66.7) 19 (73.1) 19 (57.6)
Female 22 (55.0) 15 (40.5) 11 (33.3) 7 (26.9) 14 (42.4)
Mode of delivery
Spontaneous vertex delivery 22 (5.0) 18 (48.6) 13 (39.4) - -
Vaginal cephalic delivery - - - 11 (42.3) 11 (33.3)
Vaginal breech delivery - - - 1 (3.8) 3 (9.1)
Pre-labour caesarean section 10 (25.0) 9 (24.3) 10 (30.3) 9 (34.6) 9 (27.3)
Caesarean section after onset of labour 4 (10.0) 7 (18.9) 9 (27.3) 3 (11.5) 6 (18.2)
Forceps 1 (2.5) - - - 1 (3)
Assisted breech 2 (5.0) 2 (5.4) 1 (3) 1 (3.8) 2 (6.1)
Ventouse 1 (2.5) 1 (2.7) 1 (3.8) 1 (3)
Gestational age at delivery
22-27 weeks 15 (37.5) 11 (29.7) 11 (33.3) 8 (28.6) 12 (36.4)
28-31 weeks 1 (2.5) 3 (8.1) 9 (27.3) 2 (7.1) 3 (9.1)
32-36 weeks 6 (15.0) 2 (5.4) 4 (12.1) 7 (25) 6 (18.2)
37-41 weeks 18 (45.0) 21 (56.8) 9 (27.3) 10 (35.7) 12 (36.4)
42+ weeks - - - 1 (3.6) 0 (0)
Birthweight
<500g - - 2 (6.1) 1 (3.6) 1 (3)
500<1000g 16 (40.0) 11 (29.7) 9 (27.3) 8 (28.6) 14 (42.4)
1000<1500g - 1 (2.7) 6 (18.2) 2 (7.1) 2 (6.1)
1500<2000g 5 (12.5) 3 (8.1) 2 (6.1) 2 (7.1) 2 (6.1)
2000<2500g 6 (15.0) 2 (5.4) 2 (6.1) 4 (14.3) 5 (15.2)
2500<3000g 5 (12.5) 7 (18.9) 3 (9.1) 3 (10.7) 1 (3)
3000<3500g 4 (10.0) 7 (18.9) 4 (12.1) 5 (17.9) 6 (18.2)
3500<4000g 1 (2.5) 5 (13.5) 4 (12.1) 3 (10.7) 2 (6.1)
4000g+ 3 (7.5) 1 (2.7) 1 (3) - -
Customised birthweight centile category
<3rd 13 (32.5) 3 (8.1) 6 (18.2) 8(34.8) 10(30.4)
<10th 17 (42.5)* 8 (21.6)* 9 (27.3)* 10(43.5)* 11(33.3)*
10-49th 13 (32.5) 16 (43.2) 10 (30.3) 6(26.1) 15(45.5)
50-89th 6 (15.0) 11 (29.7) 9 (27.3) 7(25.0) 6(18.2)
90th+ 4 (10.0) 2 (5.4) 5 (15.2) - 1(3)
Timing of death
2nd week of life 23 (57.5) 15 (40.5) 20 (60.6) 17 (60.7) 17 (51.5)
3rd week of life 10 (25.0) 9 (24.3) 6 (18.2) 7 (25) 12 (36.4)
4th week of life 7 (17.5) 13 (35.1) 7 (21.2) 4 (14.3) 4 (12.2)
Location of death
Neonatal unit 18 (45.0) 21 (56.8) 24 (72.7) 14 (50.0) 22 (66.7)
Ward of the maternity unit 1 (2.5) 1 (2.7) - - 1 (3)
Paediatric centre 14 (35.0) 10 (27.0) 9 (27.3) 9 (32.1) 7 (21.2)
Home 6 (15.0) 5 (13.5) - 4 (14.3) 3 (9.1)
In transit home 1 (2.5) - - 1 (3.6) -
*Includes cases from the category <3rd Centile.
** Note: Data was missing for the following variables: gender not known for two cases, mode of delivery was not known for two 
cases and birthweight centiles could not be calculated for five cases.
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Major congenital anomaly 15 (37.5%) 18 (48.6%) 19 (57.6%) 15 (53.6%) 15 (45.4%)
Central nervous system 2 2 3 1 1
Cardiovascular system 5 4 5 5 2
Respiratory system 1 - - 1 -
Gastro-intestinal system - 1 - 1 1
Musculo-skeletal system - 1 - - 2
Multiple anomalies 2 3 1 - 1
Chromosomal disorders 4 4 7 7 6
Metabolic disorders - 1 2 - 1
Urinary tract - 1 1 - -
Other major congenital anomaly 1 1 - - 1
Pre-viable (<22 weeks) - - - - -
Respiratory disorders 9 (22.5%) 5 (13.5%) 6 (18.2%) 3 (10.7%) 10 (30.3%)
Severe pulmonary immaturity 5 4 2 3 3
Surfactant deficiency lung disease 1 - 4 - 6
Pulmonary hypoplasia - - - - -
Meconium aspiration syndrome - - - - -
Primary persistent pulmonary hypertension - - - - -
Chronic lung disease/bronchopulmonary 
dysplasia
- 1 - - -
Other respiratory disorder 3 - - - 1
Gastro-intestinal disease 6 (15.0%) 1 (2.7%) 4 (12.1%) 3 (10.7%) 3 (9.1%)
Necrotising enterocolitis 5 1 4 3 3
Other gastro-intestinal disease 1 - - - 0
Neurological disorder 1 (2.5%) 7 (18.9%) 1 (3.0%) 2 (7.1%) 4 (12.1%)
Hypoxic-ischaemic encephalopathy - 3 - 1 3
Intraventricular/periventricular haemorrhage - 4 1 1 1
Other neurological disorder 1 - - - -
Infection 4 (10.0%) 1 (2.7%) 2 (6.1%) 4 (14.3%) -
Sepsis 3 1 2 1 -
Pneumonia - - - - -
Meningitis - - - 2 -
Other infection 1 - - 1 -
Injury/Trauma - - 1 (3.0%) - -
Other specific causes - - - - -
Malignancies/tumours - - - - -
Other specific cause - - - - -
Sudden unexpected deaths 3 (7.5%) 4 (10.8%) - 1 (3.6%) 1 (3%)
Sudden infant death syndrome (SIDS) 3 4 - 1 1
Infant Deaths - Cause Unascertained - - - - -
Unexplained 2 (5.0%) 1 (2.7%) - - -
No antecedents or associated obstetric factors - - - - -
Antecedents or associated obstetric factors 
present
- - - - -
Very limited information available 2 - - - -
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7.  Early neonatal deaths with a birthweight <500g 
and a gestational age at delivery <24 weeks
While not included in the calculation of perinatal 
mortality rates, we ask for notification of 
deaths in the early neonatal period of babies 
born before 24 weeks gestation and weighing 
less than 500g. For 2016, 34 such deaths 
were reported by 14 maternity units. This total 
of 34 deaths corresponds to the number of 
perinatal deaths of babies born before 24 weeks 
gestation with a birthweight less than 500g 
reported by maternity units to the Healthcare 
Pricing Office. Twenty one of the 34 deaths 
occurred in babies born between 21 and 22 
weeks gestation and eleven deaths occurred 
in babies born between 15-20 weeks gestation. 
The remaining two deaths occurred in babies 
of 23 week gestation. Details of the 34 early 
neonatal deaths born before 24 weeks gestation 
and weighing less than 500g are provided in 
Table 7.1.
Using the NPEC Neonatal Classification System, 
the assigned cause of death was pre-viable 
(<22 weeks) for 21 cases (61.8%) and severe 
pulmonary immaturity for 12 cases (35.3%). Only 
one case was recorded with cause of death 
linked to a major congenital anomaly. Based 
on the NPEC Maternal and Fetal Classification 
System, the antecedents or associated obstetric 
factors in these 34 early neonatal deaths were 
mainly Chorioamnionitis (n=14, 41.1 %) and 
spontaneous premature labour (n=12, 35.3%). 
Other causes included prolonged rupture 
of membranes (>24 hrs), major congenital 
anomaly, twin-twin transfusion, among others. 
The birthweights of the babies were in the range 
100g to 490g and their gestation at delivery 
was 15-23 weeks. Customised birthweight 
centiles calculated for the 34 babies showed 
evidence of fetal growth restriction. Twelve 
(35.3%) were small-for-gestational-age (SGA; 
<10th centile) and seven (20.6%) were severely 
SGA (<3rd centile).
All 34 babies died within 24 hours of being 
delivered, most commonly in the labour ward 
(n=28, 82.3%) but in some cases in another 
ward of the maternity unit (n=7, 20.6%).
An autopsy was performed in six cases (17.6%) 
and an autopsy was offered in a further 20 
cases. Placental histology examination was 
conducted following all but one of the 34 
deaths (97.1%).
A recurrent issue raised by maternity units 
relates to the registration of live babies born 
before the age of viability. Correspondence 
from the General Registers Office (GRO) has 
confirmed the current legislation on registration 
of such births: if an infant is born with signs of 
life, regardless of birthweight or gestational age 
at delivery, the birth is registered as a live birth 
and if the subsequent death of the infant occurs 
during the perinatal period, the death should 
then also be registered as a neonatal death.44
44 Smith B, Assistant Registrar General 2016, personal communication, 12th October.
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Birthweight Location of death Cause of Neonatal Death Autopsy Uptake  
(Yes/No)
20 316 Ward Pre-viable (<22 weeks) No (and not offered)
21 400 Labour Ward Pre-viable (<22 weeks) No (but offered)
22 470 Labour Ward Severe pulmonary immaturity No (and not offered)
21 374 Labour Ward Pre-viable (<22 weeks) No (and not offered)
21 490 Labour Ward Pre-viable (<22 weeks) No (and not offered)
21 430 Labour Ward Pre-viable (<22 weeks) No (but offered)
21 300 Labour Ward Pre-viable (<22 weeks) No (but offered)
22 460 Labour Ward Severe pulmonary immaturity No (but offered)
19 320 Labour Ward Pre-viable (<22 weeks) Yes
15 100 Ward Pre-viable (<22 weeks) No (but offered)
22 330 Ward Severe pulmonary immaturity No (but offered)
19 350 Labour Ward Pre-viable (<22 weeks) No (and not offered)
21 360 Labour Ward Pre-viable (<22 weeks) Yes
21 485 Labour Ward Pre-viable (<22 weeks) No (but offered)
22 490 Labour Ward Severe pulmonary immaturity Yes
23 410 Labour Ward Severe pulmonary immaturity No (but offered)
23 350 Labour Ward Severe pulmonary immaturity No (but offered)
22 455 Labour Ward Severe pulmonary immaturity No (but offered)
19 264 Ward Major congenital anomaly No (but offered)
19 310 Labour Ward Pre-viable (<22 weeks) No (and not offered)
22 460 Labour Ward Severe pulmonary immaturity No (but offered)
22 480 Labour Ward Severe pulmonary immaturity Yes
22 490 Labour Ward Severe pulmonary immaturity No (but offered)
19 210 Ward Pre-viable (<22 weeks) No (and not offered)
18 115 Ward Pre-viable (<22 weeks) Yes
20 350 Labour Ward Pre-viable (<22 weeks) No (but offered)
22 475 Labour Ward Severe pulmonary immaturity Yes
21 273 Labour Ward Pre-viable (<22 weeks) No (but offered)
21 376 Labour Ward Pre-viable (<22 weeks) No (but offered)
21 440 Labour Ward Pre-viable (<22 weeks) No (but offered)
16 110 Labour Ward Pre-viable (<22 weeks) No (but offered)
21 340 Labour Ward Pre-viable (<22 weeks) No (and not offered)
20 310 Labour Ward Pre-viable (<22 weeks) No (but offered)
22 445 Labour Ward Severe pulmonary immaturity No (but offered)
Note: None of the above early neonatal deaths were coroner cases.
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Appendix A: Hospital Co-ordinators and Contributors 2016
Hospital Co-ordinators Additional contributors
Cavan General Hospital Dr Rukhsana Majeed
Ms Karen Malocca
Ms Louise Dempsey
Coombe Women and Infants  
University Hospital, Dublin
Ms Julie Sloan 
Dr Naomi Burke and  
Dr Anna Durand O’Connor
Dr Sharon Sheehan
Cork University Maternity Hospital 




Dr Brendan Murphy 
Ms Linda Dawson
University Hospital Kerry Ms Mary Stack Courtney
Letterkenny University Hospital Ms Mary Lynch Ms Evelyn Smith
Mayo University Hospital
Ms Pauline Corcoran Dr Hilary Ikele
Ms Diane Brady Dr Meabh Ní Bhuinneain
Regional Hospital Mullingar Ms Marie Corbett
Midland Regional Hospital Portlaoise
Ms Emma Mullins
Ms Ita Kinsella
University Maternity Hospital Limerick
Ms Sandra O’Connor Dr Gerry Burke
Ms Margo Dunworth Dr Roy Philip
National Maternity Hospital, Dublin
Ms Fionnuala Byrne Dr Eoghan Mooney
Dr Lisa McCarthy Dr Anne Twomey
Dr Rhona Mahony 
Our Lady of Lourdes Hospital, Drogheda
Ms Fiona Mulligan Ms Siobhan Weldon 
Dr Seosamh Ó Cóigligh
Portiuncula University Hospital, Ballinasloe
Ms Priscilla Neilan
Ms Aisling Dixon





South Tipperary General Hospital, Clonmel Ms Siobhan Kavanagh




University Hospital Galway Ms Marie Hession
University Hospital Waterford
Ms Paula Curtain
Ms Margaret Coe 
Ms Emer Denn
Wexford General Hospital Ms Helen McLoughlin
73ANNUAL REPORT 2016
Appendix B: Perinatal Mortality Group Membership
Ms Bridget Boyd, Assistant Director of Midwifery, Coombe Women & Infants University Hospital 
Nominated by the Deputy Nursing Services Director, HSE
Dr Gerry Burke, Consultant Obstetrician & Gynaecologist, University Maternity Hospital Limerick 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr David Corcoran, Consultant Neonatologist, Rotunda Hospital 
Nominated by the Faculty of Paediatrics, RCPI
Dr Siobhan Gormally, Consultant Paediatrician, Our Lady of Lourdes Hospital 
Nominated by the Faculty of Paediatrics, RCPI
Ms Oonagh McDermott, Assistant Director of Midwifery, Sligo General Hospital 
Nominated by the Deputy Nursing Services Director, HSE
Professor John Morrison, Consultant Obstetrician & Gynaecologist, University Hospital Galway 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr Eoghan Mooney, Consultant Pathologist, National Maternity Hospital 
Nominated by the Faculty of Pathology, RCPI
Dr Keelin O’Donoghue, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Ms Breda O’Donovan, Clinical Midwife Manager III from 2017, University Hospital Waterford 
Nominated by the National Lead Midwife Office of the Nursing & Midwifery Services Director 
Ms Ann Rath, Clinical Midwife Manager III, National Maternity Hospital  
Nominated by the Deputy Nursing Services Director, HSE 
Dr Anne Twomey, Consultant Neonatologist, National Maternity Hospital  
Nominated by the Faculty of Paediatrics, RCPI 
Ms Patricia Williamson, Assistant Director of Midwifery, Rotunda Hospital  
Nominated by the Deputy Nursing Services Director, HSE
Ms Siobhan Whelan, Patient Representative
Prof Richard Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital  
Chair, Director of the National Perinatal Epidemiology Centre 
Ms Edel Manning, Research Midwife, National Perinatal Epidemiology Centre  
Perinatal Mortality Project Manager 
Mr Paul Corcoran, PhD, Senior Lecturer in Perinatal Epidemiology, National Perinatal Epidemiology Centre  
National Perinatal Epidemiology Centre contributor 
Ms Sarah Meaney, Research Officer, National Perinatal Epidemiology Centre  
National Perinatal Epidemiology Centre contributor
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Appendix C: NPEC Governance Committee Members 
Chair: Dr Michael Robson, Consultant Obstetrician and Gynaecologist, National Maternity Hospital
Professor Tom Clarke, Consultant Neonatologist, Rotunda Hospital (Retired)
Dr Sharon Cooley, Institute of Obstetrics and Gynaecology Representative
Ms Marie Cregan, Patient Representative, University College Cork
Professor Declan Devane, Chair of Midwifery, National University of Ireland, Galway
Dr Geraldine Gaffney, Senior Lecturer, National University of Ireland, Galway
Professor Richard Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital, 
Director of the National Perinatal Epidemiology Centre
Dr Heather Langan, Consultant Obstetrician and Gynaecologist, Sligo General Hospital
Dr Rhona Mahony, Master, National University Hospital
Professor Fergal Malone, Master, The Rotunda Hospital
Professor Eleanor Molloy, Faculty of Paediatrics Representative
Ms Connie McDonagh, Clinical Midwife Manager 3, St. Luke’s General Hospital
Dr Mary O’Mahony, Specialist in Public Health Medicine, HSE
Dr Sharon Sheehan, Master, Coombe Woman and Infants University Hospital
Ms Sheila Sugrue, National Lead Midwife, Office of the Nursing & Midwifery Services
Ms Collette Tully, NOCA Executive Director, National Office of Clinical Audit
Ms Ann O’Byrne, Chair of the national Designated Midwifery Officer Group - Home Births
75ANNUAL REPORT 2016
Appendix D: National Office of Clinical Audit (NOCA) endorsement 
of the Perinatal Mortality in Ireland Annual Report 2016 
 
 
National Office of Clinical Audit 
2nd Floor 
Ardilaun House, Block B 
111 St Stephen’s Green 
Dublin 2, D02 VN51 







Professor Richard A. Greene 
Director 
National Perinatal Epidemiology Centre 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
          01st June 2018 
 
Perinatal Mortality in Ireland, Annual Report 2015 
 
Dear Professor Greene, 
 
I write to thank you and your colleague Dr Paul Corcoran for your detailed presentation to the NOCA 
Governance Board, 24th May 2018 of NPEC’s Perinatal Mortality in Ireland – Annual Report 2016. 
  
You and your NPEC colleagues are to be congratulated for the quality of the report and manner in 
which you continue to engage with maternity services to maintain this work.   
 
The NOCA Board and Executive Team will continue to support NPEC governance efforts and in 
particular highlight the national requirement for resource commitment to ensure sustainable clinical 
audit of perinatal and maternal outcomes. 
 
Please accept this as formal endorsement from the NOCA Governance Board of the Perinatal 








Professor Conor O’ Keane FFPath FRCPI 
Chair 
National Office of Clinical Audit Governance Board 
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PERINATAL DEATH NOTIFICATION FORM 
2016 
 
CHOOSE Type of Case (TICK) 
  STILLBIRTH: A baby delivered without signs of life from 24 weeks’ gestation and/or with a birth weight of ≥ 
500g. 
 
 *If the birth occurred unattended and there was no lung aeration seen at Post Mortem (PM) and no other 




 EARLY NEONATAL DEATH: Death of a live born baby occurring before 7 completed days after birth. 
 
OR 
 LATE NEONATAL DEATH:  Death of a live born baby occurring from the 7th day and before 28 completed 
days after birth. 
 
 
* For the purpose of reporting, a ‘live born’ baby is defined as any baby born with evidence of life such as  
breathing movements, presence of a heart beat, pulsation of the cord or definite movement of voluntary 
muscles.   
 









The National Perinatal Epidemiology Centre is sincerely grateful for your contribution to this 
audit. 
 
Guidance for completing this form, with specific reference to Sections 11, 12 and 13 on Cause 
of Death, is outlined in the accompanying reference manual. 
 
The National Perinatal Epidemiology Centre also acknowledges with thanks the Centre for Maternal and Child 
Enquiry (CMACE) UK for permission to modify and use its Perinatal Mortality Notification Proforma for use in the 
Irish context.  
 
For NPEC Office use only:  
CASE NUMBER  
 
PLACE OF DEATH: 






















































SECTION 1.  WOMANS’ DETAILS  
       1.1. Mother’s age   
1.2. Ethnic group: 
     White - Irish                               Irish Traveller  
            Any other White background         Please specify country of origin ______________________________________  
      Asian or Asian Irish                    Black or Black Irish    
     Other including mixed ethnic backgrounds: Please specify  ______________________________________________      
            Not recorded 
         
 
        1.3. Marital status:      Married             Never married       Separated/Divorced     Widowed     Unknown    
 
         1.4. Living with partner / spouse?              Yes                        No                                   Unknown 
 
         1.5. Woman’s employment status at booking? 
 
             Employed or self-employed (full or part time)                      Unemployed (looking for work)            
 Student             Home maker                              Permanently sick/disabled     
Other________________       Unknown 
 
  
 1.7. Height at booking (round up to the nearest cm):  
 1.8. Weight at booking (round up to the nearest kg):    
 If weight is unavailable, was there evidence that the woman was too heavy for hospital scales?  Yes  No 
 1.9. Body Mass Index at booking (BMI):  . 
 
 1.10.a. Did the woman smoke at booking?      Yes, specify quantity smoked per day__________________ 
                                 No                     Unknown 
 1.10.b. Did she give up smoking during pregnancy?             Yes             No          Unknown     N/A 
 
 1.11. Is there documented history of alcohol abuse?  
        None recorded                  Prior to this pregnancy                  During this pregnancy  
 
           
       1.12. Is there documented history of drug abuse or attendance at a drug rehabilitation unit?  
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SECTION 2.  PREVIOUS PREGNANCIES  
2.1. Did the woman have any previous pregnancies?    If yes, please complete questions 2.2-2.4                 Yes        No 
2.2. No. of completed pregnancies ≥24 weeks and or with a birth weight ≥ 500g (all live and stillbirths):   
2.3. No. of pregnancies <24 weeks and with a birth weight < 500g:         
2.4. Were there any previous pregnancy problems? If yes, please tick all that apply below  Yes  No 
       Three or more miscarriages  Pre-term birth or mid trimester loss         Stillbirth, please specify number   
       Infant requiring intensive care    Baby with congenital anomaly              Neonatal death, please specify number   
Previous caesarean section Placenta praevia               Placental abruption      
Pre-eclampsia (hypertension &  proteinuria)          Post-partum haemorrhage requiring transfusion 
Other, please specify_______________________________________   Unknown 
 
SECTION 3.  PREVIOUS MEDICAL HISTORY 
3.1. Were there any pre-existing medical problems? If yes, please  tick all that apply below    Yes  No Unknown 
Cardiac disease (congenital or acquired)  Epilepsy  
Endocrine disorders e.g. hypo or hyperthyroidism  Renal disease 
Haematological disorders e.g. sickle cell disease       Psychiatric disorders 
Inflammatory disorders e.g. inflammatory bowel disease  Hypertension  
Diabetes  Other, please specify  ________________________  
 
SECTION 4.  THIS PREGNANCY 
4.1. Final Estimated Date of Delivery (EDD):      //      Unknown 
  Use best estimate (ultrasound scan or date of last menstrual period) based on a 40 week gestation, or the final date agreed 
in the notes. 
4.2. Was this a multiple pregnancy at the onset of pregnancy?             Yes       No 
 
4.3. Was this pregnancy a result of infertility treatment?                          Yes     No             Unknown 
 
               If yes, please specify method of fertility treatment _______________________________________________________________ 
  
       4.4 Gestation at first booking appointment:        weeks + days               Not booked         Unknown  
 
 4.5 Intended place of delivery at booking:  Name of unit _________________________________ 
 
Please specify the type of unit  
  Obstetric Unit      Alongside Midwifery Unit               Home                   Unbooked 
 
 4.6 What was the intended type of delivery care at booking?  
         Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
         Home c/o Hospital DOMINO Scheme 





        4.7a Was the care of the mother transferred from another unit with the fetus in utero?          Yes       No 
                 If yes please answer question 4.7 b  
         4.7b Gestation at time of in-utero transfer:                                      weeks + days            Unknown 
         
         
SECTION 5.  DELIVERY 
      
       5.1. Onset of labour: 
 Spontaneous          Induced  Never in labour  
 
5.2. Intended place of delivery at onset of labour:  Name of unit ____________________________ 
  
Please specify the type of unit 
 Obstetric Unit    Alongside Midwifery Unit     Home 
       
       5.3. What was the intended type of care at onset of labour?  
 Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
 Home c/o Hospital DOMINO Scheme 
 
5.4. Was the intended mode of delivery a planned caesarean section?    Yes    No  
 
5.5. Place of delivery: Name of unit ____________________________________  
 
Please specify the type of unit 
  Obstetric Unit             Alongside Midwifery Unit        Other, please specify___________________ 
 
5.6. What was the type of care at delivery?  
 Obstetric-Led Care        Midwifery -Led Care              Born Before Arrival (BBA) - Unattended      
 Self-Employed Community Midwife       Home c/o Hospital DOMINO Scheme                             
       5.7. Date and time of delivery/birth:  Date: //       Time:: 
 
5.8. What was the lie of the fetus at delivery?  
 Longitudinal                           Oblique                    Transverse   
5.9. What was the presentation at delivery?  
Vertex  Breech  Compound (includes transverse and shoulder presentations) Brow  Face    
 
5.10. What was the mode of delivery? (Please tick all that apply) 
 Vaginal cephalic delivery     Ventouse           Forceps            Assisted Breech delivery          
Vaginal Breech delivery           Pre-Labour Caesarean Section          Caesarean Section After Onset of Labour 
 
CAESAREAN SECTIONS ONLY 
 
5.11. What was the type of or indication for Caesarean Section? 
Elective - At a time to suit woman or maternity team Urgent - Maternal or fetal compromise which is not immediately life threatening    
Emergency - Immediate threat to life of woman or fetus          Failed instrumental delivery  
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SECTION 6.  ALL BABY OUTCOME 
      6.1. Sex of fetus/baby:     Male    Female     Indeterminate  
      6.2. Number of fetuses/babies in this delivery: (all identifiable including papyraceous)                   
             Birth order of this fetus/baby:   
Singleton  
 Twin 1  Twin 2   
 Triplet 1  Triplet 2                 Triplet 3  
Other multiple birth pregnancy, please specify__________         Birth Order   
       
        6.3. If from a multiple delivery, what was the chorionicity? Please tick all that apply 
Dichorionic diamniotic  Monochorionic diamniotic   Monochorionic monoamniotic Trichorionic   
 Singleton Not known 
       
        6.4. Birth weight (kg):  .  
 6.5. Gestation at delivery:  weeks + days                        Unknown 
       6.6. Was this a termination of pregnancy?   Yes  No 
              Please refer to the reference manual  
 
       6.7. Was a local hospital review of this case undertaken?      Yes  No 
               Please refer to the reference manual 
 
 
SECTION 7. MATERNAL OUTCOME 
       7.1. Admission to HDU:                                                                                                                           Yes    No  
       7.2. Admission to ICU:                                                                                                                             Yes    No  
       7.3. Maternal Death:                                                                                                                                 Yes    No 
 
 
   
SECTION 8. STILLBIRTH (If not a stillbirth, please go to Section 9) 
      8.1. At what gestation was death confirmed to have occurred?  weeks + days  
      If known, what date was death confirmed?  // 
 
      8.2. Was the baby alive at onset of care in labour?   











SECTION 9. NEONATAL DEATH ONLY 
       9.1. Was spontaneous respiratory activity absent or ineffective at 5 minutes?    Yes  No 
If a baby is receiving any artificial ventilation at 5 minutes, the assumption is absent/ineffective activity: a 0 Apgar score indicates 
absent activity.  
 
 
       9.2. Was the heart rate persistently <100bpm? ( i.e. heart rate never rose above 100bpm before death)  
                                                  Persistently <100bpm Rose above 100bpm 
      
       9.3. Was the baby offered *active resuscitation in the delivery room?                                             Yes  No 
        (*active resuscitation includes BMV, PPV, intubation, cardiac massage) 
 
 
        9.4. Was the baby admitted to a neonatal unit? (Includes SCBU and ICU)                                          Yes  No 
        9.5a. Was the baby transferred to another unit after birth?                                                                   Yes  No 
                  If yes please answer 9.5 b 
        
        9.5 b. Date and Time of Transfer to other unit after birth:    Date //         Time : 
 
   
        9.6. Date and Time of Death:                                                    Date //       Time : 
 
        9.7. Place of Death*:            Labour Ward               Neonatal Unit                 Ward          Theatre         
                                                In Transit                     Paediatric Centre           Home     
 
                                                           Name of unit:_____________________________________________ 
 
*This question refers to where the baby actually died, e.g. ‘ICU, ‘at home’ or ‘in transit’.  
 Babies are deemed to have died ‘at home’ if there are no signs of life documented in the home even if resuscitation is attemp ted. 
 A baby is deemed to have died ‘in transit’ if signs of life are documented prior to transfer but the baby was either declared dead  on arrival to  
the hospital or showed no subsequent signs of life in the hospital, despite attempted resuscitation. . 
  
SECTION 10. POST-MORTEM INVESTIGATIONS  
       10.1. Was this a coroner’s case? If yes, please complete question 10.2.                                                   Yes   No  
10.2. Has the post-mortem report been received from the coroner’s office?                                   Yes   No 
                                                                                                                                                    
10.4. Was a post-mortem performed?                  Yes                        No 
         If no, please complete question 10.5. 
10.5. Was a  post-mortem offered?                                                                                                   Yes  No 
 
10.6. Were any of the following procedures carried out after death?  
               Please tick all that apply    
         MRI                      X-Ray                  CT           External Examination          Genetic testing         
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SECTION 11. CAUSE OF DEATH AND ASSOCIATED FACTORS - STILLBIRTH & NEONATAL DEATH  
 
  11. Please TICK ALL the maternal or fetal conditions that were present during pregnancy or were  
associated with the death.  PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        11.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases      
 
 Other major congenital anomaly, please specify ________________________________________________________________ 
 
 Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
 
   Clinically                               Genetic analysis *                  Ultrasound                 
                                                      *See reference manual 
 
        11.1.2. HYPERTENSIVE DISORDERS OF PREGNANCY: 
 
Pregnancy induced hypertension    Pre-eclampsia  HELLP syndrome     Eclampsia  
 
        11.1.3. ANTEPARTUM or INTRAPARTUM HAEMORRHAGE:    
 
Praevia   Abruption    Other, please specify  _________________________________ 
 
        11.1.4. MECHANICAL:    
 
Cord compression:  Prolapse cord  Cord around neck    Other cord entanglement or knot 
Uterine rupture: Before labour During labour 
Mal-presentation: Breech                     Face  Compound  
 Transverse Other, please specify  ____________________________________  
        Shoulder dystocia:  
 
        11.1.5. MATERNAL DISORDER:       
    Pre-existing hypertensive disease   Diabetes     Other endocrine conditions (excluding diabetes)        
    Thrombophilias   Obstetric cholestasis  Uterine anomalies                       
    Connective tissue disorders, please specify______________________________________________________________________________ 
    Other, please specify_______________________________________________________________________________________________ 
 
        11.1.6. INFECTION: (confirmed by microbiology/placental histology)   
 
Maternal infection:  Bacterial    Syphilis    Viral diseases    
 Protozoal                                        Group B Streptococcus 
                                Other, please specify organism  _______________________________________________________ 
Ascending infection: 
                                                         Chorioamnionitis    Other, please specify  _________________________________ 
 
        11.1.7. SPECIFIC FETAL CONDITIONS:    
Twin-twin transfusion       Feto-maternal haemorrhage    Non-immune hydrops    Iso-immunisation    
Other, please specify ___________________________________________________________________________________________________  
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        11.1.8. SPECIFIC PLACENTAL CONDITIONS:   
    
PLEASE REFER TO THE REFERENCE MANUAL, PAGE 10, BEFORE COMPLETING THIS SECTION 
  
No abnormal histology reported 
        
Chorioamnionitis              →           Mild                             Moderate                          Severe 
        
 Fetal vasculitis             →          Arterial                    Venous                        Both 
       
      
  Maternal vascular malperfusion (uteroplacental insufficiency) 
     Please specify pathology:   
   Distal villous hypoplasia                     Placental hypoplasia 
        Accelerated villous maturation         Ischaemic  villous crowding         
       Placental infarction           →           Please specify approximate percentage involved _______________ 
 
    Retroplacental haemorrhage    →    Please specify approximate percentage of maternal surface involved _______________ 
   
       Fetal vascular malperfusion: 
             Please specify pathology 
        Patchy hypoperfusion              Scattered avascular villi         Thrombosis in fetal circulation    Fetal thrombotic vasculopathy      
 
          
 
    Cord pathology as sole finding 
         Please specify pathology 
         Hypercoiled cord                      Hypocoiled cord                            Meconium associated vascular necrosis   
           Vasa praevia                       Velamentous cord                  Other , please specify__________          
    
      Cord pathology associated with distal disease 
                  please specify associated distal disease:   
          Delayed villous maturation                    Thrombosis in fetal circulation                     
    
    
      Villous maturation defect  (distal villous immaturity/ delayed villous maturation)           
    
    
      Villitis     →          Low grade                 High grade                        With stem vessel obliteration 
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        11.1.9. INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE:     YES   
         
          What was this based on? Please tick all that apply 
 Suspected antenatally                    Observed at delivery                         Observed at post-mortem      
 
 
        11.1.10. ASSOCIATED OBSTETRIC FACTORS: Please tick all that apply   
        Birth trauma             Intracranial haemorrhage                         Subgaleal haematoma    
                                  Fracture, please specify_____________________________________________________ 
                                  Other, please specify________________________________________________________________________________ 
 Intrapartum fetal blood sample result < 7.25       Yes     No 
 
      Polyhydramnios                  Oligohydramnios            Premature rupture of membranes     
      Prolonged rupture of membranes (> 24hours)                Amniocentesis                             
 
 



















SECTION 12.  MAIN CAUSE OF DEATH: STILL BIRTH & NEONATAL DEATHS 
 
     12.1. Which condition, indicated in Section 11 as being present, was the MAIN condition or sentinel event          
causing or associated with the death.  Please refer to the post-mortem and placental histology reports.   
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal cond itions/ factors that were associated 
















12.2. Sources of information used to determine cause of death?  
               Please tick all that apply  









SECTION 13. NEONATAL DEATH ONLY:  NEONATAL CONDITIONS ASSOCIATED WITH THE DEATH 
 
 
       13.1. Please TICK ALL the neonatal conditions causing and associated with the death.  
                PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        13.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases                              
  
Other major malformation, please specify ________________________________________________________________ 
 
 
Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
 
   Clinically                                     Genetic analysis *                  Ultrasound                 
                                                              *See reference manual 
 
        13.1.2. PRE-VIABLE: (less than 22 weeks)           
 
        13.1.3. RESPIRATORY DISORDERS:    
 
   Severe pulmonary immaturity    Surfactant deficiency lung disease Pulmonary hypoplasia Meconium aspiration syndrome    
 
   Primary persistent pulm. hypertension          Chronic lung disease / Bronchopulmonary dysplasia (BPD)   




        13.1.4. GASTRO-INTESTINAL DISEASE:    
 
Necrotising enterocolitis (NEC)    Other, please specify __________________________________________________________________ 
 
 
        13.1.5. NEUROLOGICAL DISORDER:   
 
Hypoxic-ischaemic encephalopathy (HIE)                                                  
 
*Intraventricular / Periventricular haemorrhage, please specify highest grade (0 – 4) *           
    Hydrocephalus*, please tick all that apply: 
                   * Congenital              Acquired                     Communicating                   Obstructive       Other__________________            
 
 
Other, please specify______________________________________________________________________________________________ 
 
 
        13.1.6. INFECTION:   
 
Generalised (sepsis)    Pneumonia    Meningitis    Please  specify  specific organism _________________    




        13.1.7. INJURY / TRAUMA: (Postnatal)     
  
 
             Please specify_______________________________________________________________________________________________________ 
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        13.1.8. OTHER SPECIFIC CAUSES:   
 
Malignancies / Tumours              In-born errors of metabolism, please specify ___________________________________ 
Specific conditions, please specify___________________________________________________________________________ 
 
 
        13.1.9. SUDDEN UNEXPECTED DEATHS:   
 
Sudden Infant Death Syndrome (SIDS)        Infant death – Cause unascertained 
 
        13.1.10. UNCLASSIFIED: (Use this category as sparingly as possible)   
 
 
      13.2. Which condition, indicated in Section 13.1 as being present, was the MAIN condition causing or 
associated with the death.  Please refer to the post-mortem report.  In the absence of a post-mortem report, please 
refer to the death certificate.  
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associa ted 









     
      13.3. Sources of information used to determine cause of death?  
               Please tick all that apply  





SECTION 14. DETAILS OF REPORTING UNIT (Please print) 
        
   14.1. Name of reporting unit: ______________________________________________________________________ 
       14.2. Completed by 
          Name: _________________________________________________________________________________________ 
          Staff Grade: ____________________________________________________________________________________ 
          Work address: __________________________________________________________________________________ 
          _______________________________________________________________________________________________ 
          Telephone Number: _____________________ 
          E-mail Address:_________________________ 










Appendix F: Terminology for placental pathology 
Appendix G: Terminology for placental pathology 
Pathology category Specific placental findings 
Maternal vascular malperfusion Refers to the spectrum of findings related to shallow implantation of the 
placenta, often found in conjunction with PET and IUGR and often called 
utero placental insufficiency. Placental findings that enable this category 
to be applied are:  
distal villous hypoplasia  
accelerated villous maturation 
ischaemic villous crowding 
placental infarction  
retroplacental haemorrhage  
placental hypoplasia 
Fetal vascular malperfusion Refers to thrombosis or decreased flow in the fetal circulation. It may 
be difficult to distinguish arteries from veins in the placenta and 
pathology may be present in both. Findings consistent with fetal 
vascular malperfusion are: 
patchy hypoperfusion  
villous stromal-vascular karyorrhexis              
scattered avascular villi          
thrombosis in fetal circulation     
fetal thrombotic vasculopathy / extensive avascular villi 
Cord pathology  Cord pathology may exist by itself, or may be accompanied by evidence 
of other disease. The findings of cord pathology include: 
hypercoiled cord (Umbilical coiling index (UCI) of ≥ 0.3) 
cord stricture                
hypocoiled cord  (UCI < 0.1)                           
meconium associated vascular necrosis                        
velamentous or marginal (<10mm) cord insertion              
Other      
Delayed villous maturation Delayed villous maturation is the recommended term instead of distal 
villous immaturity, placental maturation defect or villous maturation 
defect. 
Chorioamnionitis The maternal and fetal inflammatory response should be staged and 
graded where possible.  
Villitis The term is used to mean villitis of unknown aetiology and assumes that 
the reporting pathologist has excluded infection where appropriate. 
Villitis is graded as either low grade or high grade and can occur with 
stem vessel obliteration. 
Other  
Note: More than one placental category may be present. 
 
 
45 Khong TY, Mooney EE et al: Sampling and definition of placental lesions. Arch Pathol Lab 
Med. 
45 Khong TY, Mooney EE et al: Sampling and definition of placental lesions. Arch Pathol Lab
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Guidance and Definitions for Completion of Section 11 & 12 
STILLBIRTHS AND NEONATAL DEATHS 
 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY 
Any genetic or structural defect arising at conception or during 
embryogenesis incompatible with life or potentially treatable but causing death 
 
Central nervous system   
Cardiovascular system 
Respiratory system 
Gastro-intestinal system  
Musculo-skeletal anomalies 
Multiple anomalies  
Chromosomal disorders 
Metabolic diseases  
Urinary tract 
Other 
HYPERTENSIVE DISORDERS OF PREGNANCY 
 




ANTEPARTUM OR INTRAPARTUM HAEMORRHAGE 
After 20 w gestation, whether revealed or not. If associated with PET, APH will be a 
secondary diagnosis. Ignore minor degrees of haemorrhage (e.g. ‘shows’, cervical 
polyps etc). Recurrent bleeding of uncertain origin followed by preterm labour should 






Any death attributed to uterine rupture, deaths from birth trauma or intrapartum 
asphyxia associated with problems in labour such as cord compression, 
malpresentation, shoulder dystocia etc. 
Antepartum deaths associated with cord entanglement in the absence of strong 
circumstantial evidence that cord compression caused death should be classified as 
having no associated factor. 
 
Cord Compression  
Prolapsecord 
Cord around neck 
Other cord entanglement or knot 




Breech / Transverse  
 Face / Compound 
 Other  
Shoulder dystocia 
MATERNAL DISORDER.  
Specify hypertensive disease present before pregnancy or any other maternal disease 
or condition sufficient to jeopardise the baby such as diabetes, cardiac disease etc.  
Infection is classified separately. 
 
Pre-existing hypertensive disease  
Diabetes  
Other endocrine conditions 
Thrombophilias 
Obstetric cholestasis  
Drug misuse   
Uterine anomalies 
Connective tissue disorders / 
Other  
INFECTION. Confirmed by microbiology / placental histology. 
Specify maternal infections sufficient to have compromised the baby which may be 
associated with congenital infection of the baby. Trans-placental transmission may 
have occurred such as CMV, toxoplasmosis etc.  
Specify only those ascending infections that are a significant factor in death. 
Chorioamnionitis sufficient to cause preterm birth may be specified for some 





Bacterial / Viral diseases 
Syphilis  /Group B Streptoccus 
Protozoal 
Other 









Twin-twin transfusion   
Feto-maternal haemorrhage 
Non-immune hydrops   
Iso-immunisation 
Other 
SPECIFIC PLACENTAL CONDITIONS. Specific placental conditions sufficient to cause 
death or be associated with fetal compromise such as IUGR. Cord problems associated 
with compression will normally be classified under ‘Mechanical’.  
 
 
Chorioamnionitis              
Fetal vasculitis                 
Maternal vascular malperfusion  
Fetal vascular malperfusion 
Cord pathology 
 Other 
INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE. IUGR may be suspected 
antenatally by abdominal circumference (AC) less than the centile threshold used to 
define IUGR locally, or decreased AC growth velocity, +/- oligohydramnios. 
 
Suspected antenatally 
Observed at delivery 
Observed at post mortem 
ASSOCIATED OBSTETRIC FACTORS. Factors recorded as Other Associated Obstetric 
Factors will be important clinical or pathological features of the pregnancy or baby but 
may not be an explanation of the death; they will often be secondary to other 
maternal or fetal conditions. Birth trauma and/or Intrapartum asphyxia should 
normally be classified primarily by the underlying cause (e.g Mechanical ). Birth 
Trauma and/or other antenatal/intra-partum factors can be recorded here either as a 


















NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS. Deaths with no explanation 
or significant associated factor. 
 
 
UNCLASSIFIED.  Cases where little or nothing is known about pregnancy or delivery 
and which cannot be fitted into any of the above categories.  
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Guidance and Definitions for Completion of Section 13: 
NEONATAL DEATH ONLY 
 
 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY 
 Any genetic or structural defect arising at conception or during embryogenesis 
incompatible with life or potentially treatable but causing death. 







Metabolic disorders  
Urinary tract  
Other 
PRE-VIABLE 
Babies (less than 22 weeks) who are non-viable at birth because of gestation but 
who show signs of life. 
 
RESPIRATORY DISORDERS 
Severe pulmonary immaturity will encompass those babies where structural lung 
immaturity is so gross as to mean ventilatory support is unsustainable at the outset. 
Surfactant Deficient Lung Disease may include babies with clinical or pathological 
evidence of hyaline membrane disease.  
Please note that neonatal deaths previously attributed to prematurity, would most 
often be captured under the subcategory of ‘severe pulmonary immaturity’. 
 
Severe pulmonary immaturity 
Surfactant deficiency lung disease 
Pulmonary hypoplasia 
Meconium aspiration syndrome 
Primary persistent pulmonary 
hypertension 
Chronic lung disease / BPD 
Other (includes pulmonary 
haemorrhage) 
GASTRO-INTESTINAL DISEASE 
Many babies with NEC will have associated sepsis which may be given as a secondary 
cause.  
 
Necrotising enterocolitis (NEC) 
Other 
NEUROLOGICAL DISORDER 
HIE includes those babies with severe hypoxic-ischaemic brain injury before birth. If 
possible, please specify if HIE was primarily of intrapartum or antepartum origin. 
Specify periventricular leukomalacia only if this is a significant factor in the infant 









Where possible specify the location of infection and whether due to bacteria, virus, 
fungus or other specific organism.   
If infection was the main cause of death please specify whether infection is 







INJURY / TRAUMA 
Post natal trauma only including iatrogenic injury. ‘Birth Trauma’ will usually be 
classified under neurological disorder e.g. HIE; the obstetric classification identifying 
the timing of the injury.  
 
 
OTHER SPECIFIC CAUSES 
Death due to specific fetal and neonatal conditions such as isoimmunisation or 
unexplained hydrops. Neonatal conditions will include aspiration, unexplained 









SUDDEN UNEXPECTED DEATHS.  
SIDS should conform to the accepted definition. Unascertained are those 
unexpected deaths that are not explained despite a full investigation including 
autopsy, but do not conform to the accepted definition of SIDS. 
 
Sudden Infant Death Syndrome 
(SIDS) 
Infant deaths – cause unascertained 
UNCLASSIFIED.  Cases where little or nothing is known about the pregnancy or 
delivery and which cannot be fitted into any of the above categories.  
 





92 PERINATAL MORTALITY IN IRELAND 
Appendix H: The Robson Ten Group Classification System
46 Robson Classification: Implementation Manual. Geneva: World Health Organization; 2017. 


